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Abstract
Autophagy is a cellular recycling process where cytoplasmic material is delivered
to the lysosome for degradation. It is fundamental for the homeostasis of cells, but
is also involved in various diseases. During autophagy, cytoplasmatic components
are sequestered by a cup-shaped membrane cistern, which closes to form a double-
membrane vesicle, the autophagosome. Upon fusion of the autophagosome with
the lysosome its contents are degraded and can be recycled. Numerous proteins
cooperate for autophagosome formation, including two intertwined Ubiquitin-like
(UBL) systems: the first UBL protein, Atg12, is conjugated to Atg5, and the conjugate
further associates with Atg16. The second UBL protein, Atg8, is conjugated to
phosphatidylethanolamine (PE) in the autophagosomal membrane, which is catalyzed
by Atg12–Atg5-Atg16. These systems are conserved in mammals, albeit more diverse.
The human system possesses several ATG12–ATG5 binding proteins, as well as at
least seven homologs of Atg8.
Previous work revealed that the components of the S. cerevisiae UBL systems
self-assemble on membranes to form an immobile structure. Based on these results
the hypothesis emerged, that the UBL proteins constitute the building blocks of
a new kind of membrane scaffold. The first aim of this thesis was to verify this
hypothesis with Atomic Force Microscopy (AFM). Therefore, Atg8 conjugation to PE
was reconstituted on supported lipid bilayers. AFM demonstrated, that indeed Atg8–
PE forms together with Atg12–Atg5-Atg16 a so far undescribed membrane scaffold.
Atg12–Atg5 associates with Atg8–PE on the membrane and forms homogeneous
complexes. These complexes are connected by Atg16 antiparallel tetramers, which
constitute the edges of the scaffold.
The second aim of this thesis was to reconstitute the two human UBL systems
in vitro. In a first step, all participating proteins were expressed and purified. This
complete set of essential components was the prerequisite for further experiments
and its reconstitution was achieved for the first time in this thesis. The interaction of
recombinantly expressed human ATG proteins on liposomes was characterized with
fluorescence microscopy, including fluorescence recovery after photo-bleaching (FRAP)
experiments. These experiments demonstrated that the conjugation efficiency of
hATG8s was homolog dependent. Furthermore, these experiments indicated that
also in the human system a membrane scaffold is assembled. These findings pave
the way towards a better understanding of the molecular basis of autophagy-related
diseases.
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Zusammenfassung
Autophagozytose ist ein zellulärer Recyclingprozess, bei dem zytoplasmatisches
Material zum Lysosom transportiert wird um dort abgebaut zu werden. Dieser Prozess
ist fundamental für das zelluläre Gleichgewicht, spielt aber auch bei verschiedenen
Krankheiten eine Rolle. Während der Autophagozytose umschließt eine becherförmige
Membran zytoplasmatische Komponenten. Diese Membran schließt sich und bildet
ein Doppelmembranvesikel, das Autophagosaom, welches mit dem Lysosom fusioniert.
Zwei gekoppelte Ubiquitin-like (UBL) Proteinsysteme sind an der Entstehung des
Autophagosomes beteiligt: Atg12, das erste UBL Protein, wird an sein Zielprotein
Atg5 konjugiert und dieses Konjugat bindet an Atg16. Das zweite UBL Protein,
Atg8, wird an Phosphatidylethanolamin (PE) in der autophagosomalen Membran
konjugiert. Diese Konjugationsreaktion wird durch Atg12–Atg5-Atg16 katalysiert.
Beide UBL Systeme sind beim Menschen konserviert, allerdings komplexer mit
mindestens sieben Atg8 Homologen.
Vorausgegangene Experimente mit S. cerevisiae Atg Proteinen deuteten darauf hin,
dass sich die Proteine der UBL Systeme zu einer immobilen Struktur zusammenfügen.
Basierend auf diesen Ergebnissen wurde die Hypothese entwickelt, dass die UBL
Proteine die Bausteine für ein neuartiges Membrangerüst bilden. Das erste Ziel dieser
Arbeit bestand darin, dieses Membrangerüst mittels Kraftmikroskopie nachzuweisen.
Dafür wurde die Konjugation von Atg8 auf oberflächengebundenen Lipiddoppelschich-
ten in vitro rekonstituiert. Tatsächlich konnte gezeigt werden, dass sich aus Atg8–PE
und Atg12–Atg5-Atg16 ein bis dahin noch nicht beschriebenes Membrangerüst zu-
sammensetzt. Dieses besteht aus homogenen Atg8–PE/Atg12–Atg5 Komplexen, die
über antiparallele Atg16 Tetramere verbunden sind.
Die zweite Aufgabe dieser Arbeit bestand darin, die humanen UBL Systeme in
vitro zu rekonstituieren. Die rekombinante Expression und Reinigung aller beteiligten
Proteine war die Voraussetzung für nachfolgenden Experimente und wurde zum
ersten Mal in dieser Arbeit erreicht. Die Wechselwirkungen der humanen ATG
Proteine wurden mittels konfokaler Fluoreszenzmikroskopie an Liposomen untersucht,
einschließlich Fluoreszenz Recovery (FRAP). Es konnte nachgewiesen werden, dass
die Konjugationseffizienz von hATG8 an die Liposomenmembran homolog-abhängig
erfolgte. Darüber hinaus lieferten die Experimente Hinweise darauf, dass sich beim
Menschen ebenfalls ein Membrangerüst aus ATG Proteinen zusammenfügt. Diese
Erkenntnisse legen den Grundstein für ein besseres molekulares Verständis von
Krankheiten, die mit Autophagozytose in Zusammenhang stehen.
3

1
Introduction
In eukaryotic cells, proteins undergo a constant turnover, which is mediated by
either one of two major degradative pathways: (1) the proteasomal pathway, which
selectively degrades mostly cytoplasmic proteins marked by ubiquitin in the cytosol,
or (2) the lysosomal pathway, which is responsible for degrading membrane proteins,
endocytosed material, and composite structures such as ribosomes or entire organelles.
Cargo delivery to the lysosome is mediated through vesicular carriers, derived by either
endocytosis or autophagy [Tai et al. 2008]. Autophagy (“self-eating”) describes the
delivery of cytoplasmic materials and organelles to the lysosome and was discovered
in the 1960s [De Duve et al. 1966]. Since protein degradation is part of cellular
homeostasis, autophagy plays important and often opposing roles in immune defense,
ageing, cancer, and neurodegeneration [Mizushima et al. 2008]. Despite its early
description, the molecular players of autophagy were not unraveled until several
screens in yeast identified the genes involved in autophagy [Tsukada et al. 1993;
Thumm et al. 1994; Harding et al. 1995]. To unify the nomenclature, the genes
involved in autophagy were later termed “ATG” (autophagy-related) [Klionsky
et al. 2003]. The identification of ATG-genes and the characterization of related Atg
proteins (‘ATG’ for human protein nomenclature) led to a better understanding of
the molecular mechanism of autophagy.
1.1. General processes of autophagy
Autophagy can be subdivided into three distinct mechanisms: macroautophagy,
microautophagy, and chaperone-mediated autophagy (CMA), see Fig.1.1 for an
overview. During macroautophagy, the most predominant and morphologically
distinct form of autophagy, a new cellular compartment - the autophagosome - is
formed. The autophagosome contains sequestered cytoplasmic components, which
are delivered to and degraded in the lysosome (vacuole in yeast) [Klionsky et al.
1999]. At the onset of macroautophagy, a small cup-shaped membrane sack is being
5
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Figure 1.1.: Overview of the main autophagic pathways, adapted from [Huang et al.
2007]. The three principal modes of autophagy are macroautophagy, microautophagy,
and chaperone-mediated autophagy, with specific degradation of selected cargo in
macro- and microautophagy. All pathways deliver cargo to the lysosome/vacuole in
yeast. The outer membrane of the autophagosome in macroautophagy is depicted in
blue, the inner membrane in light green. Macro- and micropexophagy are specific
forms of macro- and microautophagy, respectively. The Cvt pathway is a specific
variant of macroautophagy in yeast. It delivers the peptidase prApe1 to the vacuole
and uses the same components as other forms of specific macroautophagy (see also
Chapter 1.5.3).
formed, which has been termed ‘phagophore’ in yeast or ‘isolation membrane’ (IM)
in higher eukaryotes. For simplicity, the term phagophore will be used in this thesis.
To sequester cytoplasmic material, the autophagic precursor membrane expands,
which occurs by fusion of small vesicles with the phagophore [Moreau et al. 2011].
Such vesicles are thought to be derived from various donor organelles, such as the
endoplasmatic reticulum (ER), the Golgi complex, or mitochondria [Juhasz et al.
2006]. The membrane edges of the expanded phagophore fuse, giving rise to a double-
membrane surrounded autophagosome. The autophagosomal outer membrane fuses
with the lysosome to form an ‘autolysosome’ and the contents of the autophagosome,
as well as the inner membrane, are degraded [Nakatogawa et al. 2009].
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Regarding the mechanism of cargo selection, unspecific and specific macroau-
tophagy can be distinguished. Under vegetative conditions, unspecific macroau-
tophagy occurs at a low rate and is responsible for a constant turnover of cytosol,
but is induced by starvation or cytotoxic stress. This non-selective degradation of
cytoplasmic components mainly serves to recycle biopolymers, replenishing pools of
building blocks and in case of starvation providing nutrients to the cell.
In specific macroautophagy, particular cargoes including damaged mitochondria
(mitophagy, [Lemasters 2005]), pexosomes (pexophagy, [Dunn et al. 2005]) or invasive
bacteria (xenophagy, [Nakagawa et al. 2004]) are enclosed by an autophagosomal
membrane. Also, insoluble ubiquitinated protein aggregates can be selectively
degraded through autophagy [Pankiv et al. 2007]. In yeast, the Cvt (Cytoplasm-to-
vacuole-targeting) pathway transports hydrolases to the vacuole, utilizing a similar
sequestration strategy. This pathway is therefore regarded as a specialized variant of
specific macroautophagy [Baba et al. 1997].
Microautophagy describes a process in which the lysosomal membrane directly
encloses cytosole [Mijaljica et al. 2011], and can be divided into non-selective and
selective forms as well. While in non-selective microautophagy portions of the
cytoplasm are engulfed by the lysosome, selective microautophagy degrades specific
organelles, such as parts of the nucleus (piecemeal microautophagy [Roberts et al.
2003]).
During chaperone-mediated autophagy, the third form of autophagy, proteins are
selectively bound by the hsc70 chaperone that further binds to a receptor on the
lysosomal membrane (lamp2a). Proteins which possess a lysosomal targeting motif
are unfolded and translocated into the lysosomal lumen [Dice 1990]. So far, this
process has only been found in higher eukaryotes but not in yeast [Massey et al.
2004].
1.2. Regulation of macroautophagy
Under vegetative growing conditions, a low level of ‘basal’ unspecific macroautophagy,
hereafter referred to as ‘autophagy’, constantly recycles cytoplasmic components.
Together with specific autophagy, which also occurs under these conditions, this form
of autophagy is essential for cellular homeostasis [Mizushima 2005].
However, autophagy can also be ‘induced’, e. g. by nutrient deprivation or other
cellular stresses. In yeast, the main purpose of induced autophagy is the protection of
the cell against starvation conditions by replenishing building blocks, such as amino
7
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acids or fatty acids, to maintain vital cellular function. The induction of autophagy
is regulated by two major pathways, TORC1 and PKA, depending on the limiting
nutrient. The protein kinase target of rapamycin complex 1 (TORC1) responds to
the levels of nitrogen in the environment, whereas cAMP-dependent protein kinase A
(PKA) responds to carbon sources [Stephan et al. 2010]. Both kinases phosphorylate
the Atg1/Atg13 kinase complex, the earliest acting Atg complex, independently, and
therefore regulate autophagy depending on nutritional conditions [Stephan et al.
2009]. TORC1 and PKA are inhibited upon starvation, which leads to an activation
of the Atg1 kinase complex, and thereby bulk autophagy is initiated [Suzuki et al.
2007].
The regulation of autophagy in mammalian cells is more complex, since in multi-
cellular organisms, starvation conditions are not immediately detrimental for a cell.
Nevertheless, starvation induces a tissue specific autophagy response. For instance,
autophagy is highly upregulated in fast-twitching muscles upon starvation, but is
constantly active in other tissues even under non-starvation conditions, such as
thymic epithelial cells. Also, the magnitude of the autophagic response is tissue
specific [Mizushima et al. 2004]. Besides starvation, other regulatory factors include
insulin signaling [Neely et al. 1974], hormones, or growth factors [Lum et al. 2005].
Comparable to yeast, the two parallel pathways of PKA and TORC1 are responsible
for starvation induction of autophagy in mammalian cells, with crosstalk between
these pathways [Chen et al. 2011]. E. g. PKA activates TORC1, inhibiting autophagy
[Mavrakis et al. 2006], or inactivates upstream AMPK and thereby activating TORC1
[Djouder et al. 2010]. Also, other factors can influence autophagy independent of
mTOR signaling, e. g. Bcl-2 [Pattingre et al. 2005]. Bulk autophagy in mammals
is initiated by the counterpart to the Atg1 kinase complex, ULK1/2, together with
ATG13, FIP200, and ATG101 [Mizushima 2010].
In summary, autophagy is induced by nutrient deprivation, but its regulation
in mammalian cells is more complex and its full regulatory network, especially for
basal autophagy, is still unknown [Chen et al. 2011]. Certainly, a tight regulation of
autophagy is essential. Too much degradation results in autophagic cell death (type
II programmed cell death), that is morphologically distinct from apoptosis or necrosis
[Levine et al. 2005]. Yet, too little degradation would lead to an accumulation of
defective proteins and organelles in the cell [Mizushima et al. 2008].
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1.3. Molecular mechanisms of autophagy
1.3.1. Autophagy initiation
During autophagy, Atg proteins cooperate with canonical membrane remodeling
factors to orchestrate the biogenesis of autophagosomes. At least 20 ‘core’ ATG genes
are involved in all types of autophagy (Cvt, specific, and non-specific autophagy) and
participate in the formation, expansion and sealing of the phagophore. Autophagy is
induced at a specific location within the cell, which in yeast is in close proximity to
the vacuole and the ER, termed pre-autophagosomal structure (PAS) [Suzuki et al.
2001]. In mammals, autophagosomes are generated at multiple sites simultaneously.
These sites are close to ER membrane compartments enriched in Phosphatdylinositol
3-phosphate, termed omegasomes, where part of the ER membrane enwraps the
phagophore [Axe et al. 2008; Hayashi-Nishino et al. 2009]. Atg proteins are recruited
to the PAS in an hierarchic manner in yeast and humans, meaning that the protein
complexes involved act successively during autophagosome formation [Suzuki et al.
2007].
The first protein complex that is activated upon starvation in yeast is the Atg1
complex, which consists of Atg1, Atg13, and the constitutive Atg17-Atg31-Atg29
complex. Atg13 is the substrate for phosphorylation by TOR in yeast [Scott et al.
2000]. In humans, the ULK1 complex corresponds to the Atg1 complex and is
regulated by mTOR as well [Jung et al. 2009]. Upon starvation, TOR is inhibited
and Atg13 dephosphorylation is thought to trigger the assembly of the pentameric
Atg1 complex. Atg17 is an arc-shaped protein, which lead to the assumption that
Atg17 is involved in tethering highly curved vesicles [Ragusa et al. 2012]. Also, Atg17
interacts with Atg9, the only essential integral membrane protein in autophagy [Noda
et al. 2000; Sekito et al. 2009]. Atg9 vesicles show a cytoplasmic distribution in yeast
and are regarded as membrane source to initiate the formation of the phagophore
[Yamamoto et al. 2012]. However, the exact molecular mechanism of this crucial
step in autophagy is still poorly understood [Hurley et al. 2014].
In the second step of autophagy the activated Atg1 kinase complex recruits class III
phosphatidylinositol 3-kinase (PI3K) complex to the PAS. PI3K exists in a macro-
molecular complex consisting of the catalytic subunit protein Vps34, a lipid kinase,
together with the protein kinase Vps15, Atg6/Beclin 1 in humans, and either Atg14
or Vps38/UVRAG [Kihara et al. 2001]. The Atg14 containing complex is involved in
autophagy, whereas the Vps38/UVRAG containing complex regulates maturation of
endosomes [Kang et al. 2011]. The PI3K complex generates phosphatidylinositol-
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3-phosphate (PI(3)P) at the PAS [Obara et al. 2008], which recruits downstream
Atg proteins. Additionally, PI(3)P production is tightly regulated by phosphatases
and those phosphatases are recruited to the PAS as well at this early stage of
autophagosome formation [Cebollero et al. 2012].
1.3.2. The role of PROPPINs in phagophore assembly
PI(3)P at the phagophore recruits autophagy specific PROPPINs (β-propellers
that bind polyphosphoinositides), including yeast Atg18 and Atg21 [Krick et al.
2006], as well as human WIPI-proteins 1-4 (WD-repeat protein interacting with
phosphoinositides [Mauthe et al. 2011; Polson et al. 2010; Proikas-Cezanne et al.
2015]). Atg18 forms a complex with Atg2 that localizes to the edges of the phagophore
and is therefore assumed to play a role during phagophore expansion or closure [Guan
et al. 2001; Graef et al. 2013; Suzuki et al. 2013]. The human homolog of Atg18,
WIPI2b, interacts directly with proteins of the Ubiquitin-like conjugation systems
[Dooley et al. 2014]. This direct interaction was also demonstrated in vegetative
conditions for yeast Atg21 [Juris et al. 2015]. However, the molecular functions of
Atg18 and Atg21 are still largely unknown.
1.4. Ubiquitin-like (UBL) conjugation systems in
autophagy
1.4.1. Molecular mechanism of UBL conjugation systems
In autophagy, two ubiquitin-like conjugation systems exist, which act downstream in
autophagosome biogenesis, and are recruited by yeast Atg21/human WIPI2b [Juris
et al. 2015; Dooley et al. 2014]. For an overview of the two conjugation systems
see Fig. 1.2. Both are associated with autophagosomal membranes and involved in
membrane remodeling [Kirisako et al. 1999; Mizushima et al. 2001].
In yeast, two ubiquitin-like proteins, Atg12 and Atg8, are activated and conjugated
to their targets by two UBL conjugation systems. The first step in the conjugation
reaction of Atg12 is its activation by Atg7, an E1-like enzyme, in an ATP-dependent
manner. Atg7 forms a thioester bond between the C-terminal Glycine of Atg12 and
an active cysteine residue of Atg7. The activated Atg12 is then transferred to an
active cysteine residue of Atg10, which acts as an E2-like enzyme. Finally, Atg12
is permanently conjugated to its sole target Atg5 [Mizushima et al. 1998b]. Atg8
10
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Figure 1.2.: The two Ubiquitin-like (UBL) protein systems in yeast that are part of
the autophagic core machinery. The hallmark of macroautophagy is the conjugation of
the UBL protein Atg8 to the autophagosome, also referred as the ‘lipidation’. The last
step of Atg8-lipidation is catalyzed by the protein conjugate Atg12–Atg5. This complex
is the result of the second UBL conjugation process, in which Atg12 is conjugated to
its sole target Atg5. Atg12–Atg5 further associates with Atg16, a coiled-coil protein
that forms the multimeric Atg12–Atg5-Atg16 complex.
undergoes a similar process. After the cleavage of its last amino acid by Atg4, a C-ter-
minal Glycine is exposed. Atg8 is then activated by Atg7 at this C-terminal Glycine
and is subsequently transferred to Atg3, the E2-like enzyme for Atg8. Intriguingly,
the conjugation partner for Atg8 is the phospholipid Phosphatidylethanolamine (PE),
and not a protein [Ichimura et al. 2000]. Therefore, the conjugation reaction of
Atg8 is also referred to as its ‘lipidation’. This lipidation reaction is catalyzed by
Atg12–Atg5, which acts as an E3-like enzyme through direct interaction with Atg3
[Hanada et al. 2007]. Thus, the two UBL systems in autophagy are interconnected.
Furthermore, Atg16 binds to Atg12–Atg5 via an N-terminal Atg5-binding domain of
Atg16. Atg12–Atg5-Atg16 dimerizes by coiled-coil formation of Atg16 and forms a
constitutive complex of ~350 kDa [Kuma et al. 2002]. The lipidation reaction of Atg8
is organized by Atg21, a member of the PROPPIN protein family, through direct
interaction with the coiled-coil domain of Atg16 [Juris et al. 2015]. In an ATG8Δ
mutant, Atg12–Atg5-Atg16 localizes normally to the PAS. Hence, Atg12–Atg5-Atg16
11
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acts before Atg8 [Suzuki et al. 2007]. After closure of the autophagosome, Atg8
is deconjugated from the autophagosomal membrane by Atg4 [Nair et al. 2012],
whereas the conjugate Atg12–Atg5 is permanently present in the cell.
The two ubiquitin-like systems are conserved in mammals. The ATG12–ATG5
conjugate is formed by E1- and E2-like enzymes, and also functions as an E3-like
enzyme for the conjugation of mammalian ATG8 homologs to PE in membranes
[Mizushima et al. 1998a]. ATG3, ATG5, ATG7, and ATG16L1 knockout mice are
autophagy defective and neonatal lethal due to a lack of amino acids after disruption
of placental nutrient supply [Sou et al. 2008; Kuma et al. 2004; Komatsu et al. 2005;
Saitoh et al. 2008]. In contrast to yeast, at least seven human ATG8s exist, which
can be divided in two subfamilies, LC3s and GABARAPs, but so far only LC3B
is well studied [Shpilka et al. 2011]. LC3B and GABARAP knockout mice show a
normal phenotype, which hints to either redundant functions of some ATG8s or the
capacity to compensate for one another [Cann et al. 2008; O’Sullivan et al. 2005].
In general, the molecular mechanisms of UBL systems in autophagy are well
understood. Nevertheless, while serving as cargo adaptors on the inner membrane of
the phagophore, the function of Atg8/ATG8s conjugated to the outer autophagosomal
membrane remains elusive.
1.4.2. ATG12–ATG5 complexes
In humans, at least three proteins associate with ATG12–ATG5 to form a multimeric
complex, ATG16L1, ATG16L2, and TECPR1. For ATG16L1 and ATG16L2 this
complex has a size of ~800 kDa [Mizushima et al. 2003; Ishibashi et al. 2011].
ATG16L1 and AT16L2 are N-terminally homologous to yeast Atg16, including an
ATG5 binding domain and a coiled-coil domain, but possess an additional C-terminal
domain, which is dispensable for autophagosome formation [Mizushima et al. 2003;
Fujita et al. 2008b]. This C-terminal domain contains seven WD-repeats forming
a β-propeller structure that provides a platform for protein-protein interactions
[Smith et al. 1999]. For example the transmembrane protein TMEM59 interacts with
the WD-repeat of ATG16L1 to label endosomes for autophagic degradation upon
bacterial infection [Boada-Romero et al. 2013]. Similarly, a coding variant (T300A)
in the WD-repeat region causes Crohn disease, possibly due to a disturbed host cell
response upon Salmonella infection [Hampe et al. 2007; Rioux et al. 2007].
ATG16L1 shows five different theoretical splice isoforms, with experimental ev-
idence for isoform 1 and 2 in humans. Isoform 1 (ATG16L1 beta) represents the
canonical form, isoform 2 (ATG16L1 alpha) a truncated version (www.uniprot.org,
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[Zheng et al. 2004]). Both human and mouse isoforms of ATG16L1 show tissue-specific
expression patterns [Ishibashi et al. 2011; Mizushima et al. 2003].
Comparable to the yeast Atg8-conjugation system, ATG12–ATG5-ATG16L1 acts as
an E3-like enzyme for the lipidation of ATG8s [Fujita et al. 2008b]. Ectopic targeting
of ATG16L1 to the plasma membrane resulted in recruitment of ATG12–ATG5 and
LC3 lipidation at the plasma membrane [Fujita et al. 2008b]. ATG16L1 therefore
acts upstream and its recruitment initiates LC3 lipidation. Interestingly, the coiled-
coil domain of ATG16L1 is required for LC3 conjugation, since no autophagosome
formation could be observed in cells expressing ATG16L1 lacking the coiled-coil
domain and mutant mice died during the neonatal starvation period [Saitoh et
al. 2008]. This leads to the hypothesis, that dimer formation of ATG12–ATG5-
ATG16L1 plays a role for ATG8 lipidation. Additionally, Rab33B, a small GTPase,
interacts directly with ATG16L1 at its coiled-coil domain. Inhibition of this binding
attenuated autophagy, suggesting that ATG16L1 interaction with Rab33 modulates
autophagosome formation [Itoh et al. 2008; Fukuda et al. 2008]. ATG12–ATG5-
ATG16L1 is absent from closed autophagosomes, whereas LC3 serves as a marker
for phagophores and closed autophagosomes [Mizushima et al. 2001].
ATG16L2, a homologous protein to ATG16L1, interacts with ATG12–ATG5 as well
and forms a similar multimeric complex. ATG16L2 is able to form hetero-oligomers
with ATG16L1, however it is not localized to phagophores and not involved in
starvation-induced autophagosome formation. This functional discrepancy is most
likely based on the coiled-coil region of ATG16L2, which shows only 20,7% amino
acid identity to ATG16L1 [Ishibashi et al. 2011], further emphasizing the importance
of the ATG16L1 coiled-coil domain in autophagosome formation.
The third protein, which can interact with ATG12–ATG5, is tectonin β-propeller
repeat containing protein 1 (TECPR1) and was identified during an autophagy screen
in humans [Behrends et al. 2010]. ATG12–ATG5 exclusively interacts with either
ATG16L or TECPR1. Recently, it could be shown that TECPR1 also binds PI(3)P
and seems to act at later stages of autophagosome biogenesis, however the molecular
mechanisms of TECPR1 remain unclear [Chen et al. 2012].
1.5. Atg8/ATG8 specificities
Initially, ATG8 proteins in mammals were not discovered in the context of autophagy,
but as part of other cellular processes. LC3s were co-purified with microtubule-
associated proteins (MAPs) A1 and A2 [Kuznetsov et al. 1987; Mann et al. 1994],
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GATE-16 was found to be involved in intra-Golgi protein transport [Legesse-Miller
et al. 1998], and GABARAP was found to interact with GABAA receptors [Wang
et al. 1999]. However, apart from this initial characterization in these pathways, no
further implications for non-autophagic functions of ATG8 proteins exist, implying
that their main activity is restricted to autophagy. An involvement in autophagy
was first reported for MAP1LC3 [Kabeya et al. 2000].
At least seven ATG8 homologs were identified in humans. These can be di-
vided into two related subfamilies based on their sequence homology: LC3s and
GABARAPs. Humans posses four LC3 genes (encoding for MAP1LC3A, MAP1-
LC3B, MAP1LC3B2, MAP1LC3C), with MAP1LC3A encoding for two splicing
isoforms. The GABARAP family comprises two GABARAP genes (encoding for
GABARAP, GABARAPL1/GEC1), and one GATE-16 gene (encoding for GABA-
RAPL2/GATE-16) [Shpilka et al. 2011]. The existence of a fourth GABARAP,
GABARAPL3, could only be shown on a transcriptional level [Xin et al. 2001].
ATG8s are expressed in all tissues to different extents [Xin et al. 2001; Mizushima
et al. 2004]. E. g., GABARAP shows higher expression in endocrine glands compared
to other tissues, whereas GABARAPL1 is mainly expressed in the central nervous
system [Nemos et al. 2003]. Interestingly, the three human GABARAPs display
a higher protein sequence identity with yeast Atg8 (55-56%) compared to the five
human LC3s (36-40%) [Szalai et al. 2015].
The hATG8 family is characterized by an ubiquitin-fold domain and an N-terminal
domain consisting of two α-helices, which most likely undergo conformational changes
upon conjugation of ATG8 proteins to PE, regulating protein-protein interactions
[Paz et al. 2000; Coyle et al. 2002]. These α-helices differ in the ATG8 proteins.
The LC3 subfamily possesses a basic first α-helix, in contrast to an acidic α-helix in
GABARAP and GATE-16 [Sugawara et al. 2004]. The biological relevance of the
different homologs is largely unknown, especially during autophagosome biogenesis.
1.5.1. Atg8/ATG8 in autophagosome formation
In yeast, the amount of Atg8 molecules at the PAS correlates with the size of
autophagosomes [Xie et al. 2008a]. Similar results have been obtained for human
ATG8 proteins, however homolog-dependent. LC3B colocalizes with GABARAP
and GATE-16 to autophagosomes [Kabeya et al. 2004; Weidberg et al. 2010]. A
knockdown of either LC3 or GABARAP subfamily blocks autophagic flux [Weidberg
et al. 2010]. Strikingly, the phagophore structures labeled with YFP-ATG5 appeared
smaller upon knockdown of LC3s and larger upon knockdown of GABARAPs.
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This let to the assumption that the subfamilies act sequentially in autophagosome
formation. Specifically, these results suggested that the LC3 family functions in the
elongation process of the phagophore, whereas the GABARAP family acts at a later
stage, possibly closure of the autophagosome [Weidberg et al. 2010]. Interestingly,
it was reported by another study that autophagic sequestration of bulk cytosole
depends solely on GABARAPs and not on LC3s [Szalai et al. 2015]. This obvious
discrepancy could result from cell-type and organism dependent differences (HeLa
cells vs. rat hepatocytes) and have not been resolved yet. Still, the authors of the
second study confirmed the futility of LC3s in autophagy in prostate cancer cells
[Szalai et al. 2015]. Intriguingly, the homolog for GABARAP in C. elegans, LGG-1,
is essential for autophagosome formation, whereas the LC3 homolog, LGG-2, is
involved in lysosomal recruitment through interaction with the tethering complex
HOPS [Manil-Ségalen et al. 2014]. To make the roles of ATG8-homologs even more
complex, it was reported that a knockout mouse for GABARAP did not show a
specific phenotype [O’Sullivan et al. 2005]. Taking these results together, ATG8
proteins seem to have non-redundant activities during autophagosome formation,
but show partial compensation in case of homolog specific knockouts.
1.5.2. Involvement of Atg8/ATG8 proteins in sealing,
tethering and fusion
Atg8 is a key molecule during autophagosome formation, but its function on the
outer membrane of the phagophore was unclear. Therefore it was hypothesized that
Atg8 might play a role in sealing of the phagophore, tethering of small vesicles to the
phagophore or in fusion of the autophagosome with the vacuole. Atg8 is deconjugated
from autophagosomes by Atg4 shortly before or after completion, and upon a defect in
deconjugation in ΔATG4 cells, autophagy is reduced [Kirisako et al. 2000]. Similiarly,
incomplete autophagosomes that are defective in membrane closure were observed
with a protease-inactive form of ATG4B, suggesting that without deconjugation the
autophagosome cannot form [Fujita et al. 2008a]. Recently another study in yeast
supported these findings. A protease protection assay demonstrated that the defect in
autophagy was caused by a sealing defect, suggesting that autophagosome sealing is
impaired if Atg8 is retained on membranes. This defect in deconjugation further led
to mislocalization of Atg8 to the vacuolar membrane, and missing dissociation of other
Atg proteins from the autophagosomal membrane [Nair et al. 2012]. These results
imply that Atg8 deconjugation is necessary for efficient autophagosome biogenesis
and fusion with the vacuole.
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In contrast to the finding that the deconjugation of Atg8 seems to be important for
autophagosome biogenesis, several studies try to shed light on the possible membrane
tethering and hemifusion activity of Atg8, however with partially contradicting
results. It was suggested in an in vitro reconstitution system, that Atg8-PE and its
human homologs tether and hemifuse vesicles for phagophore expansion [Nakatogawa
et al. 2007; Weidberg et al. 2011]. However, so far no in vivo evidence was found to
support these findings. The suggested hemifusion function could be ruled out, since
it requires non-physiological PE concentrations [Nair et al. 2011]. Instead, SNARE
proteins are responsible for vesicle fusion in autophagosome maturation in yeast
[Nair et al. 2011], as well as mammals [Moreau et al. 2011]. Regarding tethering
of small vesicles to the phagophore, it was discovered that the TRAPPIII complex
is involved in vesicle tethering at the PAS [Lynch-Day et al. 2010]. Since TRAPP
complexes have functions as vesicle tethers in ER-to-Golgi and trans-Golgi-endosome
trafficking [Barrowman et al. 2010], it is very likely that TRAPPIII, instead of Atg8,
is responsible for tethering vesicles at early steps of autophagosome formation.
LC3 is phosphorylated at T50. With respect to possible involvement of Atg8/
ATG8 proteins in fusion of the autophagosome with the vacuole/lysosome, it was
demonstrated that loss of this phosphorylation impairs the fusion of autophagosomes
with lysosomes and thereby blocks autophagy. The phosphorylation could be essential
for recruiting other factors to the autophagosome, which are necessary for fusion, such
as SNAREs or tethering factors [Wilkinson et al. 2015]. Indeed, an interaction partner
of ATG8 proteins was identified recently, which regulates autophagosome-lysosome
fusion: PLEKHM1 (Pleckstrin homology domain containing protein 1). PLEKHM1
is thought to bridge autophagosomal and lysosomal membranes by binding to ATG8
proteins and Rab7/HOPS complex and thereby mediating autophagosome-lysosome
fusion [McEwan et al. 2015]. The HOPS complex (homotypic fusion and protein
sorting) is known as tethering complex on the vacuole [Balderhaar et al. 2013] and
Rab7 has already been previously shown to regulate autophagic progression [Gutierrez
et al. 2004]. The fusion of the autophagosome with the lysosome is mediated by the
SNARE protein Syntaxin17 on autophagosomes in mammals and Drosophila [Itakura
et al. 2012; Takáts et al. 2013]. Syntaxin17 also interacts with the HOPS complex
for autophagosome-lysosome fusion [Jiang et al. 2014; Takáts et al. 2014], but with
PLEKHM1 an adaptor protein was characterized that directly binds to LC3s and
GABARAPs via its LIR motif [McEwan et al. 2015]. Remarkably, in C. elegans, the
interaction to the HOPS complex is mediated only by the LC3 homolog LGG-2, not
the GABARAP homolog LGG-1 [Manil-Ségalen et al. 2014], indicating a reverse
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order of function compared to humans [Weidberg et al. 2010]. In summary, these
results indicate that Atg8/ATG8 proteins act as interaction partners for canonical
tethering and fusion machines, such as PLEKHM1, SNAREs and HOPS complex,
during fusion of autophagosomes with the vacuole/lysosome.
1.5.3. Specificities of Atg8/ATG8-interacting proteins
Besides the role of Atg8 in autophagosome biogenesis, Atg8 and its human homologs
are involved as cargo adaptor at the inner autophagosomal membrane. In the
Cytoplasm-to-vacuole pathway in yeast, Ape1, a peptidase, is linked to Atg19, which
interacts with Atg8 on the inside of phagophores [Chang et al. 2007]. Similarly, Atg34
connects α-mannosidase to Atg8 [Suzuki et al. 2010]. In mammals, Ubiquitin-marked
proteins are linked via p62 to ATG8 family members for degradation [Pankiv et al.
2007]. Those protein-protein interactions depend on an Atg8 Interacting Motif
(AIM ) that is present in yeast Atg8-interacting proteins. This motif is also called
LC3 Interacting Region (LIR) in mammals. The consensus sequence for the AIM
and LIR motif is W-X-X-L (X being any amino acid), and it binds to conserved
hydrophobic pockets in Atg8 and its mammalian homologs [Noda et al. 2008].
Another protein interacting with Atg8 is Atg1 [Nakatogawa et al. 2012b; Kraft
et al. 2012]. Similarly, ATG8 proteins interact with ULK1/2, as well as other
members of the ULK1/2 complex. Interestingly, all interacting proteins of the human
Atg1 complex had a strong preference for GABARAPs over LC3s, implying that
GABARAP family members could act as scaffold proteins for the assembly of the
human Atg1 complex [Alemu et al. 2012]. Conversely, the adaptor protein FYCO1,
that links autophagosomes to microtubules, prefers LC3 [Pankiv et al. 2010]. Finally,
the interaction of NDP52, which exclusively binds to LC3C in Salmonella infected
cells, accounts for efficient antibacterial autophagy in these cells [von Muhlinen et al.
2012]. A proteomic analysis provided a broader view on ATG8 homolog-interacting
proteins, and demonstrated that two-thirds of the interacting proteins are either
specific for LC3 or GABARAP, and only one-third is interacting with both [Behrends
et al. 2010]. These homolog-specific interactions could partially explain the diversity
of ATG8 proteins. For an overview of the different reported roles of human ATG8
homologs see figure 1.3.
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Figure 1.3.: Schematic overview of LC3 and GABARAP family functions, corre-
sponding to the current literature, adapted from Weiergräber et al. [2013]. Light blue
boxes represent protein-protein interactions, light orange boxes represent protein-lipid
interactions. Strikingly, protein-protein interactions hint towards GABARAPs being
involved earlier in autophagosome biogenesis compared to LC3s, whereas protein-lipid
interactions suggest that LC3 proteins act earlier.
1.6. Objectives of this study
Autophagy plays crucial roles in cell homeostasis, as well as in development, age-
ing, and diseases, such as cancer and neurodegeneration. Therefore a complete
understanding of the underlying molecular mechanisms is indispensable for identi-
fying new therapeutic targets. Still, a systematic picture of autophagy, specifically
autophagosome biogenesis, is lacking [Xie et al. 2008b]. Conjugation of Atg8 to
the autophagosomal membrane is a key process in autophagy, but its function on
the outer membrane remained elusive, mainly due to the dynamic nature of au-
tophagosome formation in vivo. Therefore, studying the interaction of Atg proteins
in controlled conditions with each other and with membranes in vitro, allows for
deeper insights into Atg8 function as well as its interplay with other Atg proteins.
The ubiquitin-like (UBL) systems of autophagy in yeast have been studied in
our lab previously. Based on in vitro and in vivo analyses of Atg8, Atg12–Atg5,
and Atg16, the hypothesis emerged that Atg12–Atg5 not only acts as an E3-like
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enzyme for Atg8, but has a second structural function in forming a protein scaffold
on autophagosomes together with Atg16 and Atg8. The first aim of this study was to
verify the hypothesis of this previously unknown protein scaffold on autophagosomal
membranes. Due to its capability to image structures with submicrometer resolution
and in physiological conditions, it was the aim to utilize Atomic Force Microscopy to
provide direct evidence by imaging the proposed scaffold in vitro.
The second aim of the thesis was to test whether such a protein scaffold also
exists for humans. Comparable to yeast, ATG12–ATG5 enzymatically conjugates
human ATG8 proteins to membranes. However, ATG12–ATG5 interacts with three
different proteins in the human system. On top of these three ATG12–ATG5
complexes, at least seven different ATG8 proteins were identified in human cells.
The biological relevance of these homologs is largely unknown, especially during
autophagosome biogenesis. Hence, the goal was to reconstitute the human autophagic
UBL systems in vitro. Subsequently, possible functional differences of ATG8s
should be analyzed. Furthermore, FRAP experiments (Fluorescence Recovery After
Photobleaching) should be performed to provide an indication for a protein scaffold
by measuring protein and membrane mobility with fluorescently labeled proteins on
giant unilamellar vesicles. Thereby, protein combinations can be determined that
are able to form the hypothesized scaffold.
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Materials and Methods
2.1. Reagents
Media and buffers for gels and blotting used in this thesis can be found in table 2.1
and table 2.2, respectively. Buffers for protein purification are listed in table 2.3.
Table 2.1.: Media for bacteria and yeast cultivation.
Medium Components
LB (lysogeny broth) 1 % tryptone (Bacto)
[Bertani 1951] 0.5 % yeast extract (Bacto)
0.75 % NaCl (AnalaR Normapur)
TB (terrific broth) 1.2 % tryptone
[Tartoff et al. 1987] 2.4 % yeast extract
0.5 % glycerol (Carl Roth)
17 mM KH2PO4 (Carl Roth)
72 mM K2HPO4 (Carl Roth)
SOC (super optimal broth 2 % tryptone
with catabolite repression) 0.5 % yeast extract
[Hanahan 1983] 8.56 mM NaCl
2.5 mM KCl (Carl Roth)
10 mM MgCl2 (Merck)
10 mM MgSO4 (Carl Roth)
20 mM glucose (Merck)
SD (synthetic defined) 0.67 % Difco YNB (Becton, Dickinson & Company)
2 % Glucose
amino acid mix (specific for yeast strain)
SD-N 0.17 % Difco YNB
2 % glucose
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Table 2.2.: Buffers for agarose gels, SDS-PAGE and Western Blotting.
Buffer Components
TAE buffer 40 mM Tris
20 mM acetic acid (Sigma-Aldrich)
1 mM EDTA, pH 8.0 (Carl Roth)
5x Laemmli-SDS loading buffer 225 mM Tris-HCl, pH 6.8
50 % glycerol (Carl Roth)
5 % SDS (Carl Roth)
0.05 % bromphenol blue (Merck)
250 mM DTT (PanReac AppliChem)
SDS Running Buffer 25 mM Tris-HCl
19.21 mM glycin (Sigma-Aldrich)
0.1 % SDS
MES SDS Running Buffer 50 mM MES (PanReac AppliChem)
50 mM Tris-HCl, pH 7.3
0.1 % SDS
1 mM EDTA
Coomassie Staining Solution 0.25 % (w/v) Coomassie R-250 (PanReac AppliChem)
30 % (v/v) ethanol (Sigma-Aldrich)
10 % (v/v) acetic acid
Coomassie Destaining Solution 40 % (v/v) ethanol
10 % acetic acid
Shrinking Solution 50 % (v/v) methanol (Sigma-Aldrich)
3 % (v/v) glycerol
Blotting (Transfer) Buffer 25 mM Tris
192 mM glycine
0.1 % SDS
20 % (v/v) methanol
Tris-buffered saline with Tween 20 25 mM Tris-HCl, pH 7.6
(TBS-T) buffer 150 mM NaCl
0.05 % Tween-20
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Table 2.3.: Lipidation buffer and buffers for protein purification.
Medium Components
Lipidation buffer 12.5 mM Tris-HCl, pH 7.4 (Sigma-Aldrich)
137.5 mM NaCl (AnalaR Normapur)
Lysis Buffer 100 mM Tris-HCl, pH 8.0
300 mM NaCl (500 mM for ATG16L1)
20 mM imidazole, pH 8.0 (Merck)
10 % glycerol
5 mM β-mercaptoethanol (Merck)
0.5 % protease inhibitor cocktail (Sigma)
Washing Buffer (Ni-NTA) 50 mM Tris-HCl, pH 8.0
300 mM NaCl (500 mM for ATG16L1)
5 mM imidazole, pH 8.0
10 % glycerol
5 mM β-mercaptoethanol
Elution Buffer (Ni-NTA) 50 mM Tris-HCl, pH 7.4
300 mM NaCl (500 mM for ATG16L1)
500 mM imidazole
10 % glycerol
Running Buffer 25 mM Tris-HCl, pH 7.4
(size exclusion chromatography, SEC) 275 mM NaCl (400 mM for ATG16L1)
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2.2. AFM experiments with yeast UBL proteins
2.2.1. Sample preparation
Supported Lipid Bilayer (SLB) preparation All lipids were purchased from
Avanti Polar Lipids. Lipid stocks and mixtures were stored at -80°C. The lipid
mixture for supported lipid bilayers (SLBs) consisted of Cholesterol (20 mol %), 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, 39.9 mol %), 1-palmitoyl-2-oleo-
yl-sn-glycero-3-phospho-L-serine (POPS, 20 mol %), 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphoethanolamine (POPE, 20 mol %), and lissamine-rhodamine-PE (0.1 mol %)
in chloroform (7 mM total lipid concentration). Supported lipid bilayers (SLBs) were
prepared by deposition and fusion of small unilamellar vesicles (SUVs, Chiantia et al.
[2005]). The first step in production of SUVs are multilamellar vesicles (MLVs).
For MLVs, 50µl of lipid mixture was dried in a glass vial under nitrogen flow while
turning the vial constantly for an even distribution of the lipid film. For complete
evaporation of chloroform the vials were further dried for 1 h in vacuum. For lipid
resuspension 50µl lipidation buffer (table 2.3) was added to the vial. The mixture
was vortexed until the MLV solution was opaque. MLVs could now be aliquoted
and stored at -20°C. For SUV preparation, the MLV mix was diluted 10 fold with
lipidation buffer and sonicated for 10 minutes until the solution was clear. 180 µl of
this SUV suspension was deposited with 4µl CaCl2 (0.1 M) and 16 µl lipidation buffer
on the support for 20 minutes at room temperature and then rinsed at least 10 times
with lipidation buffer to remove unbound vesicles. As support either plasma-cleaned
glass coverslips or silanized mica was used. Mica was freshly-cleaved and glued to
plasma-cleaned coverslips, before silanization was carried out Heinemann et al. [2011].
The silanization charges the surface positively. Therefore, the negatively charged
lipids adhere better to the support.
Atg8 lipidation reconstitution Recombinantely expressed proteins were purified
as described in chapter 2.5.2 or provided by V. Beier (Atg8-Alexa488). Atg7, Atg3,
Atg8, DTT and ATP were incubated at 30°C for 10 minutes, as well as Atg12–Atg5
together with Atg16. Both incubated mixtures were mixed, pipetted on top of the
SLB, and further incubated for 15 minutes. The final concentrations in the AFM
chamber were 0.6µM Atg8, 0.2 µM Atg7, 0.2 µM Atg3, 0.1 µM Atg12–Atg5, 0.1 µM
Atg16, 0.5 mM ATP, and 0.1 mM DTT. The membrane was washed again with
lipidation buffer to remove unbound proteins.
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2.2.2. LSM (Laser Scanning Microscopy)
For SLB experiments a combined atomic force/laser scanning microscopy setup was
used with a JPK Instruments Nanowizard III BioAFM mounted on top of a Carl
Zeiss laser scanning microscope (LSM) Meta 510 system. For LSM measurements, a
40x NA 1.2 UV-VIS-IR C Apochromat water-immersion objective was used. Alexa488
labeled Atg8 was excited with a 488 nm Argon-ion laser and the Rhodamine-labeled
bilayer with a 543 nm Helium-neon laser, respectively. Typical images were acquired
with a size of 57.6 x 57.6 µm, 512 x 512 pixel resolution, and 3.2µs per pixel scanning
rate.
For fluorescence recovery after photobleaching (FRAP) experiments, a 28 x 28µm
area at the center of the LSM images was photobleached for 40 seconds with 100%
laser power (both lasers), followed by image scanning every 75 seconds for a maximum
of 45 minutes.
2.2.3. AFM (Atomic Force Microscopy)
Binnig et al. [1986] developed the first scanning probe microscope suitable for the
investigation of biological samples in aqueous solutions - the Atomic Force Microscope
(AFM). In Atomic Force Microscopy, different kinds of interactions (e. g. van-der-
Waals or electrostatic) between a sharp tip and a sample are measured, usually by
scanning the sample with the tip mounted on a flexible cantilever arm. Therefore,
an image with AFM is not obtained with light that passes through several lenses
(like in a conventional light microscope), but through topological scanning of the
sample with the tip and utilizing the deflection of a laser beam from the cantilever
(Fig. 2.1). Thus, the microscopic resolution is not restricted to the wavelength of
light. Biological samples can be imaged in physiological buffer conditions with very
high resolution.
Here, AFM imaging was performed in intermittent-contact (also called ‘tapping’,
see Fig. 2.1, C) mode with BioLever Mini BL-AC40TS-C2 cantilevers (Olympus)
with typical spring constants of 0.09-0.1 N/m. The scan rate was set to 0.8 Hz, the
setpoint close to 0.85 V, resolution to 512 x 512 pixels and cantilever oscillation
frequency between 18 and 25 kHz. The force applied on the sample maintained at
the lowest possible value by continuously adjusting the setpoint and gains during the
imaging. Height, error, deflection and phase-shift signals were collected and images
were line-fitted as required with JPK SPM Data Processing Software v4.2.47 (JPK
Instruments). Estimations of particle sizes were performed using the analysis software
Gwyddion v2.30 (Czech Metrology Institute), demonstrated in Fig. 3.6, p. 54. Height
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Figure 2.1.: Scheme illustrating the working principle of Atomic Force Microscopy
(AFM)1. (A) Representation of an Atomic Force Microscope mounted on an inverted
optical microscope, comparable to the setup used in this thesis. An infrared laser beam
is deflected from the cantilever tip. Cantilever deflection is measured by a 4-quadrant
photodiode. A feedback-loop connects laser detection with the piezo-electric scanner to
apply constant force on the sample. (B) Imaging is often performed in scanning mode.
Deflections of the cantilever correspond to height changes in the sample. By scanning
the sample a topological image is acquired. (C) Delicate samples can be imaged in
tapping mode (depicted here). Here, the cantilever oscillates while scanning the sample.
Topological changes are recorded through amplitude changes of the cantilever.
analysis was performed using the histogram representation of at least 8 different 2
x 2 µm bilayer areas on 2-3 distinct bilayer-protein samples. The height-scales for
the images shown were adjusted for best visualization of the protein layer on top
of the bilayer. Large white spots correspond to height-saturated protein aggregates.
Orthogonal 3D height images in Fig. 3.3 were processed from the average of the trace
and retrace raw images with posterior 3 pixel-sized mean value fitting.
2.3. Electron Microscopy of yeast cells
S. cerevisiae strains were provided by B. Hofmann and listed in table 2.4. Strains
were cultured in SD medium at 30°C and 180 rpm (table 2.1), supplemented with
appropriate antibiotics and amino acids (table 2.4). When cells reached an optical
density of 0.8 at 600nm (OD600), nitrogen starvation was induced by washing cells
twice with SC-N (nitrogen starvation medium, table 2.1), followed by incubation
in SC-N medium for 4 hours. 9.5 ml cell suspension with an OD600 of 0.8 were
1http://www.freesbi.ch/en/illustration/figures
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harvested before and after starvation by centrifugation (3 minutes, 1500 g). Fixation,
embedding, and staining were performed according to the PIPES-KMnO4 protocol
for ultrastructural analysis [Wright 2000]. Cells were mixed 1:1 with prefixative
solution (table 2.5), incubated for 5 minutes, centrifuged, and incubated in prefixative
at 4 °C over night.
Table 2.5.: Prefixative [Wright 2000].
Prefixative
0.2 M PIPES, pH 6.8 (Sigma-Aldrich)
0.2 M sorbitol (Carl Roth)
2 mM MgCl2 (Merck)
2 mM CaCl2 (Carl Roth)
4 % glutaraldehyde (Carl Roth)
Next, samples were washed 3 times
with water, postfixated in 2 steps with
2 % potassium permanganate (Sigma-
Aldrich) for 45 minutes, washed, and
stained with 1 % uranyl acetate (Serva)
for 1 hour. All washing steps were carried
out with autoclaved water to reduce car-
bon content of samples through evapora-
tion of CO2 during boiling. Subsequently,
samples were gradually dehydrated in
rising ethanol solutions (25 %, 50 %,
75 %, 95 %) by centrifugation (5 minutes,
1500 g) and resuspension. During dehydration steps, Spurr’s resin according to the
‘standard medium firm’ formula was prepared (Spurr Low Viscosity Embedding Kit,
Sigma-Aldrich). After 5 incubations in 100 % ethanol, samples were resuspended in
2:1 ethanol:resin and incubated for 2 hours. Samples were centrifuged for 5 minutes at
1500 g and resuspended in 1:1 ethanol:resin. To allow ethanol evaporation, samples
were incubated rotating over night at room temperature in 2 ml tubes (Eppendorf)
sealed with Pleated Dialysis Tubing (Snake Skin, Thermo Scientific). Next, sam-
ples were centrifuged and incubated twice in 100% resin for 1 hour, followed by
another resin exchange and incubation for 2 hours under vacuum. Samples were then
transferred to beem embedding capsules (size 3, Electron Microscopy Sciences) and
Table 2.4.: Yeast strains (all BY4741) used for electron microscopy.
Name Specifications
WT (Y BH222) pep4Δ::clonNat
ΔAtg18 (Y BH223) pep4Δ::clonNat, atg18Δ::KanMX6
ΔAtg21 (Y BH224) pep4Δ::clonNat, atg21Δ::KanMX6
ΔAtg18, ΔAtg21, Atg21oe pep4Δ::clonNat, atg18Δ::KanMX6, atg21Δ::hphNT1
(Y BH225 with pCEN BH37) pCEN BH37: pTL58 (Leu2 auxotrophy), pPmaI–Atg21
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incubated for 2 hours under vacuum. Capsules were centrifuged for 20 minutes at
2000 g in 2 ml tubes for pelleting the cells to the bottom of the capsule and subjected
to vacuum for 1 hour. Finally, samples were hardened at 70°C for 24 hours.
Embedding capsules were cut open, samples were mounted in a sample holder, and
60-100 nm thin sections were prepared using a Ultracut E ultramicrotome (Reichert-
Jung). The ultra-thin sections were mounted on copper grids coated with Formvar
carbon film (FCF-100-Cu, Electron Microscopy Sciences), post stained for 2 minutes
with Reynolds’ lead citrate (kindly provided by R. Kutlesa) and washed twice with
autoclaved water for 10 minutes.
Imaging was performed on a JEM-1230 (JEOL) transmission electron microscope
with a voltage of 80 kV, images were acquired using an Orius SC1000 digital camera
(Gatan) and the accompanying software DigitalMicrograph.
2.4. Cloning of human ATG proteins
To express the desired proteins of the human autophagic UBL protein cascades
recombinantly, the cDNAs had to be cloned into suitable expression vectors. cDNA
clones of human proteins were picked from the ImaGenes cDNA Library at the
in-house Biochemistry Core Facility (table 2.6) and 5 ml cultures were grown over
night at 37°C and 180 rpm. Plasmid DNA was isolated using the QIAprep Spin
Miniprep Kit (Qiagen) and cDNA was amplified by polymerase chain reaction (PCR),
according to primer melting temperature and cDNA length. A general PCR protocol
and cycle, as used in this thesis, are described in table 2.7. Successful PCR was
monitored by agarose gel electrophoresis, using self-casted 1 % agarose gels (Biomol)
containing 0.01% Ethidium Bromide solution (Serva) in TAE-buffer (table 2.2).
All cDNAs were sequenced (sequencing primers in table 2.12) and mutations,
as well as deletions were reversed using the QuikChange Lightning Site-Directed
Mutagenesis Kit (Agilent). All primers were purchased from Metabion and can be
found in chapter 2.11, p. 41.
SLIC cloning Cloning of cDNAs into expression vectors provided by the Biochem-
istry Core Facility (MPIB) was performed via Seamless Ligation Independent Cloning
(SLIC, Li et al. [2007]). Expression vectors by the Core Facility are constructed such,
that identical PCR cDNA fragments can be fused to different tags or into different host
vectors for recombinant protein expression [Scholz et al. 2013]. To reduce vector back-
ground, the toxic ccdB gene is expressed in non-linearized or non-recombined vectors.
Commonly used vectors were pCoofy1 (pETM14 with N-His6), pCoofy3 (pETM33
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Table 2.6.: cDNA clones used in this thesis, with corresponding vector and antibiotic
resistance.
Protein Clone Name Vector Resistance
ATG3 IRAUp969F0878D pOTB7 Chloramphenicol
ATG5 IRATp970D01100D pBluescriptR Ampicillin
ATG7 IRAUp969E0513D pOTB7 Chloramphenicol
ATG10 IRATp970F0347D pCMV-SPORT6 Ampicillin
ATG12 IRATp970G0416D pCMV-SPORT6 Ampicillin
ATG16L1 IRAUp969E0649D pOTB7 Chloramphenicol
TECPR1 IRATp970H0679D pCMV-SPORT6 Ampicillin
LC3A IRATp970E0811D pCMV-SPORT6 Ampicillin
LC3B IRAUp969H0456D pOTB7 Chloramphenicol
GABARAP IRCMp5012H094D pCR-BluntII-TOPO Kanamycin, Zeocin
GATE-16 IRAUp969E1044D pDNR-LIB Chloramphenicol
Table 2.7.: General PCR protocol and cycle using Phusion polymerase (New England
Biolabs, NEB). Annealing temperature was adjusted to primer melting temperatures
and elongation step to cDNA length, respectively.
PCR protocol
10 µl 5x GC or HF Buffer (NEB)
4 µl dNTP Mix (2.5 mM each, NEB)
2.5 µl Forward Primer (10 µM)
2.5 µl Reverse Primer (10 µM)
1 µl template (10-20 ng)
ad 49 µl H2O (Mol. biol. grade, AppliChem)
1 µl Phusion DNA Polymerase (NEB)
PCR cycle
98°C 30 sec Denatuaration
98°C 10 sec Denat.
30 cycles45-72°C 30 sec Anneal.
72°C 30 sec/kb Elong.
72°C 10 min Final Extension
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Table 2.8.: Reaction mixture and PCR cycle for colony PCR using Pfu-Polymerase
(provided by the Core Facility). Colonies were first swirled in medium for over night
culture before tip was dipped into PCR reaction mixture. Annealing temperature was
adjusted to primer melting temperatures(Tm) and elongation step to cDNA length,
respectively.
PCR reaction (25 µl)
15 µl H2O
2.5 µl 10x Pfu-buffer
2 µl dNTP Mix (2.5 mM each)
2.5 µl Forward Primer (5 µM)
2.5 µl Reverse Primer (5 µM)
0.25 µl Pfu-Pol (5U)
PCR cycle
95°C 5 min Cell rupture
95°C 1 min Denat.
30 cyclesTm-5°C 30 sec Anneal.
72°C 2 min/kb Elong.
72°C 5 min Final Extension
with N-His6-GST), pCoofy4 (pETM44 with N-His6-MBP), pCoofy16 (pETM66 with
N-His6-NusA), and pCoofy37 (modified by M. Perna, N-MBP, C-His10). These vec-
tors also contain a Precission protease cleavage site to remove the N-terminal tag
and pCoofy37 a TEV protease cleavage site to remove the C-terminal His10. Insert
amplification was performed with primers that consist of a gene specific sequence and
a sequence that is homologous to the linearized vector. For recombination, linearized
vector and amplified insert were added, together with Recombinase A (provided
by Core Facility), and incubated for 30 minutes at 37°C, according to the protocol
[Scholz et al. 2013]. 3-10 µl of the Plasmid were incubated with chemically competent
cells for 30 minutes on ice, 45 seconds at 42°C, 2 minutes on ice and 1 hour in SOC
medium (table 2.1) under constant shaking. Cells were then plated on LB-Agar
plates with the correct antibiotics and incubated over night at 37°C. Colonies were
picked and Colony-PCR (table 2.8) was performed to verify insert ligation into the
vector. 5 ml cultures were grown over night at 37°C and 180 rpm. 0.5 ml were used
for glycerol stocks (25 % glycerol), which were stored at -80°C, and Plasmid DNA
was isolated using the QIAprep Spin Miniprep Kit from the remaining 4.5 ml.
Atg8 homologs Four Atg8 homologs were used in this thesis, namely LC3A,
LC3B, GABARAP, and GATE-16. The cDNA of these proteins was amplified from
their original vectors (table 2.6) and cloned into pCoofy1, pCoofy3, pCoofy4, and
pCoofy16. All cDNAs corresponded to isoform 1, and therefore to the ‘canonical’
form, as specified in Uniprot. Uniprot identifiers are Q9H492-1 for LC3A, Q9GZQ8-1
for LC3B, O95166-1 for GABARAP, and P60520-1 for GATE-16. Primers used for
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amplification are listed in table 2.13, p. 42. Primers were designed such, that the
last amino acid in the construct corresponds to the C-terminal Glycine of hATG8s,
to which PE is conjugated. Therefore, pre-processing by ATG4 is unnecessary for
the conjugation reaction. Furthermore, an N-terminal cysteine was introduced for
fluorescent labeling using the QuikChange Lightning Site-Directed Mutagenesis Kit.
Primers used for site-directed mutagenesis are listed in table 2.13, p. 42.
ATG3 The cDNA for ATG3 corresponded as well to isoform 1 (Uniprot identifier
Q9NT62-1) and was cloned into pCoofy1, pCoofy3, pCoofy4, and pCoofy16 with the
primers specified in table 2.13, p. 42).
ATG12–ATG5 ATG7 and ATG10 are E1- and E2-like enzymes, respectively, and
are therefore part of the enzymatic cascade needed for production of the ATG12–
ATG5 conjugate. Sequencing revealed, that the ATG10 cDNA contained a deletion
of two nucleotides and two point mutations. These errors were removed by site-
directed mutagenesis and the sequence corresponded to the ‘canonical’ sequence of
isoform 1 (Uniprot identifier Q9H0Y0-1, mutagenesis primers in table 2.13, p. 42).
ATG7 cDNA retrieved from the ImaGenes library corresponded to isoform 2, but
was correct apart from that (Uniprot identifier O95352-2). ATG5 cDNA matched
the long and therefore canonical isoform (Uniprot identifier Q9H1Y0-1), as well as
ATG12 (Uniprot identifier O94817-1).
For the production of ATG12–ATG5 several cloning strategies were tried in parallel.
One was to express all proteins involved in the enzymatic cascade individually.
Therefore the cDNAs of ATG7, ATG10, ATG12 and ATG5 were cloned from their
original vectors (table 2.6) into pCoofy1, pCoofy3, pCoofy4, and pCoofy16 (primers
in table 2.13, p. 42). A second cloning strategy was the coexpression of all proteins
that are part of the cascade at once. There, the aim was to produce the ATG12–
ATG5 conjugate directly and purify it, without having to express and purify four
individual proteins. For this strategy, a polycistronic expression vector, pST39, was
used [Tan 2001] and cloning was performed with the In-Fusion HD Cloning Kit
(Clontech). Additionally, also vectors were produced that contained a fifth protein,
either ATG16L1 or TECPR1. These two proteins are known to bind ATG12–ATG5
and it was hypothesized that they could stabilize ATG12–ATG5. For polycistronic
expression, a ribosomal-binding site, consisting of a translational enhancer and a
Shine-Dalgarno sequence, was inserted between the coding cDNAs. Cloning was
performed in two steps, since five proteins are likely too many for a correct insertion
in one step. In the first step, pST39 was linearized and cDNAs of ATG7, ATG10,
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and ATG12 were ligated into pST39. In a second step, the vector was linearized
once again and cDNAs of ATG5 and either ATG16L1 or TECPR1 were ligated.
Additionally, an N-terminal His6-tag was added to ATG5, for subsequent affinity
chromatography (primers in table 2.15, p. 43). First test-expressions did not yield the
ATG12–ATG5 conjugate, which is why the vector was modified further. The turning
point in the production of ATG12–ATG5 was the substitution of ATG7 isoform 2
to isoform 1. Isoform 1 contains 27 additional amino acids, which were added into
pST39 by linearization and religation of pST39 via recombination. Further, due
to an unstable N-terminus of ATG12, a His10-tag was added to ATG12 instead of
the His6-tag on ATG5, and a Precission Protease cleavage site was introduced to
remove the tag later. Temporarily, ATG12 was expressed in this construct as MBP
fusion protein, however later it was found that MBP was not necessary for ATG12
stabilization. These modifications were also achieved by recombination (primers in
table 2.15, p. 43). Finally, a codon for cysteine was added to the N-terminus of ATG12
for fluorescent labeling of the conjugate by site-directed mutagenesis. Figure 2.2
depicts the final pST39 vector cloned for ATG12–ATG5 production.
Figure 2.2.: Vector map of final pST39 polycistronic expression vector for ATG12–
ATG5. cDNA of all proteins part of the enzymatic cascade for conjugate production
(ATG7, ATG10, ATG12, ATG5) were cloned into the vector backbone, separated by
ribosomal binding sites (RBS). A His10-tag for affinity purification was cloned at the
N-terminus of ATG12, followed by a cleavage site for precission protease to remove the
tag after purification. Furthermore, a cysteine codon was added before the methionine
start-codon for labeling of the protein.
ATG7 As mentioned in the above paragraph, the cDNA picked from the library
for ATG7 translated for isoform 2. As found out for ATG12–ATG5, only isoform 1
is enzymatically active. ATG7 is needed as purified protein as well for conjugating
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hATG8 to PE. Therefore isoform 1 linearization and recombination was also performed
on pCoofy vectors with the same primers (Atg7 IF1 lin fw and rv, table 2.15, p. 43).
Aside from pCoofy1, 3, 4, and 16, other vectors and strains were tried for expression
of ATG7, amongst others pCoofy37 or pGEX-6P-1. However, expression in E. coli
was not successful, which is why ATG7 was also cloned in vectors suitable for
insect cell expression. Due to the modular expression system provided by the
Core Facility, the same primers could be used for SLIC of ATG7 (table 2.13) into
pCoofy27 (pFastBac, N-terminal His7), pCoofy28 (pFastBac, N-terminal His6-GST),
and pCoofy29 (pFastBac, N-terminal His6-MBP).
ATG16L1 The cDNA for ATG16L1 picked from the library contained one deletion
of four base pairs and one point mutation. These errors were removed by site-directed
mutagenesis (primers in table 2.17). Furthermore, the ATG16L1 cDNA translated for
isoform 2. The missing 19 amino acids were cloned into the cDNA by linearization
and religation (SLIC, primers in table 2.17, Uniprot identifier Q676U5-1). ATG16L1
cDNA was cloned into pCoofy1, 3, 4, 16, 37, 27, 28, and 29 via SLIC cloning (primers
in table 2.17), as well as in pST39 via InFusion cloning (primers in table 2.15).
Furthermore, truncated forms of ATG16L1 were cloned, namely ATG16L1ΔWD,
missing the WD domain, into pCoofy1, 3, 4, 16, 37, and pST39 (AA 1-319, as in
Boada-Romero et al. [2013]), and two forms of ATG16 N-terminus, both containing
only the ATG5 binding domain, into pCoofy1, 3, 4, 16, 37, and pST39 (AA 1-43 and
AA 11-43, as in Otomo et al. [2013]).
TECPR1 TECPR1 cDNA was picked from the library and corresponded to isoform
1, the canonical form (Uniprot identifier Q7Z6L1-1). The cDNA was cloned into
pCoofy1, 3, 4, 16, 27, 28, 29, and pST39 by SLIC (primers in table 2.17 and 2.15).
2.5. Protein expression and purification
2.5.1. Test expressions
To test, whether the desired protein is expressed and if the protein is soluble, test
expressions were carried out. Strains usually tested were E. coli BL21 (DE3) Rosetta,
BL21 (DE3) with pGKJE8 vector (TaKaRa), which encodes for E. coli chaperones
dnaK-dnaJ-grpE and groES-groEL, and E.coli Arctic Express. 50 ml cultures were
grown in LB or TB medium (table 2.1) with the appropriate antibiotics at 37°C
(Arctic Express at 30°C) and 180 rpm over night. Expression of chaperones was
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induced after 1 hour with 0.2 % (W/v) arabinose (Carl Roth) and 5 ng/ml tetracycline
(PanReac AppliChem). When cells reached an OD600 of 0.4, cultures were cooled to
18°C and at OD600 = 0.6 induced for recombinant protein expression with 0.3 mM
IPTG (Carl Roth) and grown over night. Samples of OD600 = 1 were taken before
and after induction (‘non-induced’ and ‘induced’). 25 ml culture was harvested
for 10 minutes at 4000 g, resuspended in 1 ml lysis buffer (table 2.3), and lysed by
sonication. The lysate was centrifuged for 20 minutes at 17000 g and the pellet
was resuspended in 1 ml 6 M Urea (Sigma-Aldrich; ‘pellet’). The supernatant was
collected (‘soluble fraction’) and incubated with 30µl of washed Ni-NTA agarose
(QIAGEN) for 1 hour at 4°C. The His-tag of the recombinant proteins binds to Ni2+
and therefore bound proteins are not removed by washing. Ni-NTA was washed twice
with lysis buffer by centrifugation and resuspension (‘pull-down’). All samples were
mixed with SDS loading buffer (table 2.3) and subjected to SDS-gel electrophoresis.
2.5.2. Large scale expression and purification
Final constructs, which were used for protein production are listed in table 2.9. These
constructs were chosen based on best test-expression and purification results.
Table 2.9.: Final constructs, strains, and medium used for protein expression of
human ATG proteins. ICM Insect cell medium.
Insert Vector Expression strain Medium
Cys-LC3A pCoofy1 E.coli, Rosetta LB
Cys-LC3B pCoofy1 E.coli, Rosetta LB
Cys-GABARAP pCoofy1 E.coli, Rosetta LB
Cys-GATE-16 pCoofy1 E.coli, Rosetta LB
ATG3 pCoofy1 E.coli, Rosetta LB
ATG7-ATG10-His10-Cys-ATG12-ATG5 pST39 E.coli, Rosetta LB
ATG7 pCoofy27 Insect cells SF9 ICM, 5 % FCS
ATG16L1 pCoofy29 Insect cells H5 ICM
ATG16L1 N-Terminus (11-43) pCoofy4 E.coli, Rosetta LB
ATG16L1ΔWD pCoofy4 E.coli, Rosetta LB
Expression ATG3 and ATG8 proteins were produced by setting up 3 liters of
culture with appropriate antibiotics, growing the cells at 37°C and 180 rpm to OD600
of 0.6, inducing them with 0.3 mM IPTG and growing them for 3 hours at 37°C.
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For all other proteins expressed in E. coli, as well as yeast proteins used in AFM
experiments (cloned constructs provided by V. Beier), 6 liters culture were set up,
grown at 37°C and 180 rpm until they reached an OD600 of 0.3, cooled to 18°C,
induced with 0.3 mM IPTG when an OD600 of 0.6 was reached, and grown over night
at 18°C and 180 rpm.
For production of ATG7 and ATG16L1, SF9 (ATG7) and H5 (ATG16L1) insect
cells were grown to 1x106 cells/ml in EX-CELL 420 serum-free medium (Sigma-
Aldrich), supplemented with 5 % Fetal Bovine Serum (FCS, heat inactivated, F4135,
Sigma) for SF9 cells. Baculovirus-infected insect cells (BIICs) were provided by the
Core Facility and added in a ratio of 1:4000 (ATG7) or 1:1000 (ATG16L1). Cultures
were shaken for 72 hours at 25°C and 85 rpm.
Purification E. coli cells were harvested by centrifugation at 4500 g for 10 minutes,
resuspended in lysis buffer, supplemented with protease inhibitor cocktail (Sigma)
and benzonase (Sigma). E. coli cells were either lysed by sonication (2x 10 minutes)
or with a microfluidizer processor (Microfluidics). Insect cells were harvested by
centrifugation at 2000 g for 15 minutes, washed with Dulbecco’s phosphate buffered
saline (DPBS, Gibco) and resuspended in lysis buffer. ATG7 and ATG8 buffers did
not contain β-mercaptoethanol and ATG16L1 (as well as its constructs) lysis buffer
contained 500 mM NaCl. Insect cells were lysed using a dounce homogenizer.
After lysis, cell suspensions of E. coli and insect cells were treated equally. Cell
suspension was centrifuged at 45000 g for 1 hour and the supernatant was incubated
with 1-2 ml Ni-NTA agarose for 1 hour at 4°C. Unbound proteins were removed by
washing with washing buffer, which contained 5 mM imidazole and competes for
binding to Ni2+ ions. Recombinant proteins were eluted with elution buffer, containing
500 mM imidazole and therefore removing also His-tagged proteins. Washing and
elution buffer for ATG16L1 and its constructs contained 500 mM NaCl. Except
for ATG16NT(11-43), where the fusion protein was purified, the affinity tag of the
recombinant proteins was removed by incubation of the eluate with PreScission
protease for 45 minutes at room temperature in presence of 5 mM DTT (AppliChem)
and 1 mM EDTA (Carl Roth). The digested proteins were subjected to size-exclusion
chromatography (SEC) with size exclusion buffer (table 2.3) on a HiLoad 16/60
Superdex 75 (Atg16, ATG3, ATG8 proteins) or Superdex 200 column (all others;
both columns GE healthcare). ATG16L1 size exclusion buffer contained 400 mM
NaCl. Chromatography was performed on an ÄKTAexplorer (GE healthcare).
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Mass spectrometry All purified proteins were pooled and concentrated using
Vivaspin cellulose centrifugation filters according to the size of the protein (Sartorius
stedim). Subsequently, proteins were flash frozen in liquid nitrogen and stored at
-80°C. Protein concentrations were determined using a Pierce BCA Protein Assay
Kit (Thermo Scientific), according to the manufacturer’s protocol. To confirm the
identity of the protein, samples were analyzed with Liquid Chromatography-Mass
Spectrometry (LC-MS), using an Aeris WIDEPORE C4 column with 3.6 µm particle
size and 300 Å pore size (Phenomenex) with an acetonitrile gradient from 30 % - 80 %
(v/v) in 15 minutes, coupled to an ESI-MS microTOF (Bruker Daltonik, operated by
the Core Facility). Both water (solution A) and acetonitrile (solution B) contained
0.05 % trifluoroacetic acid. All mass spectra were calibrated with sodium formate
standard and detection ranged from 800 to 3000 Da in positive mode.
2.6. Protein and lipid labeling
Proteins were labeled by maleimide-coupling of fluorescent dyes to cysteine residues.
To avoid sterical hindrance of the fluorescent dyes, N-terminal cysteine residues
were introduced for hATG8s and ATG12–ATG5 (chapt. 2.4). ATG16L1 possesses 12
native cysteines, therefore an additional N-terminal cysteine was considered not to
be necessary. Used dyes were CF405M (Biotium), Alexa Fluor 488 C5 maleimide
(Molecular probes), and Atto590 maleimide (ATTO-TEC). Proteins were labeled
immediately after size exclusion chromatography to avoid disulphide-bond formation.
In the absence of a reducing agent, the fluorescent dye was added in a 1:1 molar
ratio (protein : dye) to the protein (GABARAPs, ATG12–ATG5, ATG16L1) and
incubated for 1 hour at room temperature. To remove unbound dye, labeled proteins
were subjected to desalting, using either two consecutive HiTrap Desalting columns
(GE healthcare), or Zeba Spin Desalting Columns (7k MWCO, Thermo scientific,
for ATG16L1). LC3A and LC3B were binding to the desalting matrix. Therefore,
LC3A and LC3B were labeled with a molar ratio of 1:0.8 and unlabeled dye was not
removed, because it was assumed that the dye was completely bound to the proteins.
The concentration and degree of labeling was determined spectroscopically according
to the manufacturer’s protocol.
Phosphatidylethanolamine (PE) was labeled with Atto680 NHS-Ester (ATTO-
TEC). For labeling, 0.63 mM Atto-680-NHS (in DMSO) was first mixed with
17.64 mM triethylamine (Alfa Aesar), in a second step mixed with 0.84 mM POPE
or DOPE in chloroform, and incubated for 1 hour at room temperature.
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2.7. Gel electrophoresis and Western Blotting
Gel electrophoresis SDS-PAGE gels with different concentrations of polyacry-
lamide were prepared, according to the size of the protein to be analyzed. Concen-
trations of resolving and stacking gels are stated in table 2.10. 10-15 µl sample and
marker were loaded. For SDS-PAGE and gradient gels (NuPAGE 4-12 % Bis-Tris
gels, Novex), BenchMark Protein Ladder (Novex) was used, for Urea-SDS-PAGE and
gels that were intended for Western Blotting, Sharp Pre-Stained Protein Standard
(Novex) was used. SDS-PAGE and Urea-SDS-PAGE gels were run in SDS running
buffer, gradient gels in MES SDS running buffer (table 2.2). Electrophoresis was
performed at 40 mA for SDS-PAGE, at 16 mA for Urea-SDS-PAGE gels, and at 200 V
for gradient gels. Gels were stained with coomassie staining solution for 1 hour and
destained using Destaining solution. To remove water from the gels and therefore
avoid rupture during drying, gels were placed into shrinking solution (table 2.2) and
dried between two cellophane sheets (Carl Roth).
Western Blotting Western Blotting was performed with SDS-PAGE gels. Gels
were equilibrated in blotting buffer for 10 minutes (table 2.2) and PVDF membrane
(Bio-Rad) was activated for 1 minute in methanol. Blotting was performed in a
semi dry blotting chamber at 15 V for 45 minutes. Membrane was then blocked
in 5 % milk (Carl Roth) in TBS-T buffer (w/v, Carl Roth) for 1 hour at room
temperature, washed 3 times in TBS-T and incubated with primary antibody at
4°C over night. Membrane was washed 3 times with TBS-T for 10 minutes each,
incubated in secondary antibody for 1 hour at room temperature, and washed again
3 times. Specifications of antibody dilutions can be found in table 2.11. Blots were
developed using SuperSignal West Femto Substrate kit (Thermo Fisher Scientific)
and chemiluminescence was detected with a luminescent Image Analyzer LAS-3000
(Fujifilm).
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Table 2.10.: Concentrations for polyacrylamide gel electrophoresis (PAGE) with
variable percentage of acrylamide. The same stacking gel mixture was used throughout.
Urea-SDS gel was prepared according to Nakatogawa et al. [2012a].
SDS-PAGE (4 gels)
resolving gel stacking gel
7.5 % 10 % 12 % 15 %
H2O (Milli-Q grade) 14.8 ml 12.2 ml 10.2 ml 7.2 ml 6.2 ml
1.5 M Tris-HCl, pH 8.8 7.6 ml 7.6 ml 7.6 ml 7.6 ml
0.5 M Tris-HCl, pH 6.8 2.5 ml
30 % Acrylamid/Bisacrylamid
7.5 ml 10 ml 12 ml 15 ml 1.34 ml
(37.5:1, Carl Roth)
10 % SDS 300 µl 300 µl 300 µl 300 µl 100 µl
TEMED (Serva) 40 µl 40 µl 40 µl 40 µl 10 µl
25 % APS (Serva) 40 µl 40 µl 40 µl 40 µl 20 µl
Urea-SDS-PAGE (1 gel) 13.5 %
Urea 3.6 g
30 % Acrylamid/Bisacrylamid 4.5 ml
1.5 M Tris-HCl, pH 8.8 2.5 ml
10 % SDS 100 µl
TEMED 10 µl
25 % APS 40 µl
Table 2.11.: Antibodies used in this thesis; BSA Bovine Serum Albumin.
Primary Antibodies Dilution
Mouse anti-His 1:2000 in 3 % milk
(No. 05-949, Millipore)
Rabbit anti-Atg12 (Human specific) 1:1000 in 5 % BSA (VWR)
(No. 2010, Cell Signaling Technology)
Rabbit anti-Atg7 (human, mouse & rat) 1:1000 in 5 % BSA
(No. A2856, Sigma-Aldrich)
Secondary Antibodies Dilution
Goat anti-mouse, horseradish peroxidase conjugate 1:4000 in 3 % milk
(No. AP308P, Merck Millipore)
Goat anti-rabbit, horseradish peroxidase conjugate 1:4000 in 3 % milk
(No. 611-1302, Rockland Immunochemicals)
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2.8. Preparation of Liposomes
Large unilamellar vesicles The lipid mixture for large unilamellar vesicles
(LUVs) consisted of 20 mol % Cholesterol, 49.9 mol % POPC, 10 mol % POPS, 20 mol %
POPE, and 0.1 mol % lissamine-rhodamine-PE in chloroform (7 mM total lipid con-
centration). 1 mg total lipid was dried under rotation in a small glass vial (8 x 70 mm,
Duran) under nitrogen flow and further in vacuum over night. Lipids were resus-
pended with 1 ml lipidation buffer (table 2.2) by vortexing for 1 minute repeatedly
until mixture was opaque, containing multilamellar vesicles (MLVs). LUVs were
produced by extruding the MLV mixture using a Mini-Extruder (Avanti) and a
100 nm pore size membrane (no. 800309, Whatman).
Giant unilamellar vesicles The lipid mixture for giant unilamellar vesicles
(GUVs) consisted of 20 mol % Cholesterol, 39.9 mol %POPC, 10 mol % POPS, 30 mol %
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and 0.2 mol % Atto680-
DOPE in chloroform (provided by L. Dempfle, 7 mM total lipid concentration).
GUVs were prepared by electroformation, using custom-made teflon chambers [Be-
taneli et al. 2012]. 7µl of lipid mixture were spread evenly on two platinum wires and
dried in vacuum for 30 minutes. The chamber was assembled, containing 600 mM
sucrose solution (osmolarity 600 mOsm/l). Electroformation was induced by applying
an alternating electric current (2 V, 10 Hz) for 1.5 hours, followed by a reduced
frequency of 2 Hz for 30 minutes, to detach vesicles from the electrodes. GUVs were
diluted 1:1 with 600 mM sucrose solution.
2.9. In vitro lipidation reaction
GUV experiments The hATG8 proteins were preincubated with ATP, DTT,
ATG7 and ATG3, for thioester intermediate formation, and ATG12–ATG5 was
preincubated with ATG16L1 for complex formation, in SEC running buffer (table 2.3)
for 30 minutes at 37°C. Final concentrations were: 0.1 mM DTT, 1 mM ATP/Mg2+,
1 µM ATG7, 1.5 µM ATG3, 1 µM ATG7, 6 µM hATG8, and 0.5 µM ATG12–ATG5-
ATG16L1. hATG8s were used in a 2:1 ratio of unlabeled and labeled protein. After
separate preincubation, protein mixtures were combined. During incubation time,
8-well microscopy chambers (Lab-Tek) were coated with BSA (5 mg/ml in 25 mM Tris,
pH 7.4) by covering the complete bottom of the chamber, incubating for 10 minutes
at room temperature and then washing the chamber with lipidation buffer.
Final samples were prepared by pipetting 100µl of GUV suspension in the coated
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chambers, together with 100 µl of combined preincubated proteins and mixing care-
fully to not disrupt GUVs. Due to this 1:1 dilution, final buffer concentration
corresponded to the lipidation buffer, because proteins were preincubated in SEC
running buffer (= 2x lipidation buffer, table 2.3). For conjugating hATG8s to GUVs,
samples were incubated further for 1 hour at 37°C.
Thioester intermediate detection Proteins were directly mixed in lipidation
buffer, but otherwise treated similarly as in GUV experiments, except of conjugating
LC3A to LUVs instead of GUVs. The reaction was stopped by adding 3x sample buffer
without DTT and heating the protein mixtures for 5 minutes at 42°C, to not disrupt
thioester bonds. Samples were subjected to gradient gels for thioester intermediate
detection, and Urea-SDS-gels for detecting conjugated LC3A [Nakatogawa et al.
2012a].
2.10. Confocal microscopy
Microscopy experiments with human proteins were conducted on a Zeiss LSM780
confocal laser scanning microscope with a 63x/1.4 NA objective. 405 nm, 488 nm,
594 nm, 561 nm, and 633 nm laser lines were used for excitation of CF405M, Alexa488,
Atto590, rhodamine, and Atto680, respectively. For overview images, at least 3
different non-overlapping positions were chosen. Images were acquired using Zeiss
ZEN 2011 software and analyzed with FIJI [Schindelin et al. 2012].
FRAP experiments on GUVs For FRAP experiments, ~10 % of one GUV was
bleached with 100 % of all lasers used in the respective experiment and 2 iterations.
Recovery was observed for 20 cycles over 6-8 minutes. For FRAP analysis with
Zeiss ZEN 2011, additional regions of interest (ROIs) were chosen as references for
background and non-bleached fluorescence (same GUV). Recovery was fitted with
an exponential fit for one mobile species, and immobile fractions (100% -I1) were
determined. The following formula was used for fitting:
I = IE − I1 ∗ exp(−t/T1)
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2.11. Primers
Table 2.12.: Sequencing primers used in this thesis.
Protein Primer Name Primer Sequence
general
SP6 atttaggtgacactatagaa
T7 fw taatacgactcactataggg
M13-FP tgtaaaacgacggccagt
M13-RP caggaaacagctatgacc
GST-seq catggacccaatgtgcctg
MBP seq rv cggtgtctgcattcatgtgtttg
pCoofy27 seq ctatagttctagtggttggctacg
ATG3
Atg3 Hs 91 Fw caggtgtaattaccccagaagag
Atg3 Hs 696 Fw gcacatgtatgaagacatcagtc
ATG5
Atg5 Hs 180 fw gagacaagaagacattagtgag
Atg5 Hs 796 fw catattagtatcatcccacagcc
Atg5 Hs 83 rv gtatggttctgcttccctttcag
ATG7
Atg7 Hs 426 fw ccacttctactattggttttgc
Atg7 Hs 1028 fw gattggttcctactttagacttgg
Atg7 Hs 1599 fw cctcctgggctcatcgctttttgc
Atg7 Hs 606 rv cagcaccatgttctcatcatac
ATG10
Atg10 Hs 225 fw cgagctacccttggatgattg
Atg10 seq rv cttcagagttaaaggtctcccatc
ATG12
Atg12 188 fw gagacactcctattatgaaaacaaag
Atg12 Hs 174 rv ggagtgtctcccacagcctttagc
ATG16L1
Atg16L1 Hs 135 fw gtcagatcttcattcagtgttgg
Atg16L1 Hs 589 fw gagaaagcccaggaagccaatcg
Atg16 Hs 931 fw ccagctactgccttgtgtgtc
Atg16L1 Hs 1204 fw gcgcggattgtctcaggaagtc
Atg16L1 Hs 45 rv ctcagttgctccgagatgtgg
Atg16L1 Hs 1204 rv gacttcctgagacaatccgcgc
TECPR1
TECPR1 Hs 236 fw ccatgggcggcttctgtgag
TECPR1 Hs 567 fw ccccttcaacgacctctctgtag
TECPR1 Hs 1190 fw gcttcttcggtgatgaggtgaggg
TECPR1 Hs 1782 fw ggagaacttcagacactacgagc
TECPR1 Hs 2415 fw ggccagcagcaccagtaacatc
TECPR1 Hs 3016 fw gacggctccgccttctaccg
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Table 2.13.: Primers for SLIC cloning of human Atg8 homologs, ATG3, ATG10,
ATG12, and ATG5. Gene specific sequences are marked in blue. (First part) Primers
for SLIC cloning of hATG8s. The C-terminal Glycine is marked in green. (Second
part) Primers for site-directed mutagenesis for introduction of cysteine (orange) at
N-terminus before Start-Codon. (Third part) Primers for SLIC cloning of human
ATG3. (Fourth part) Primers for site-directed mutagenesis of ATG10. Changed
bases are marked in green. (Fifth part) Primers for SLIC cloning of ATG7, ATG10,
ATG12, and ATG5. Gene specific sequences are marked in blue.
Primer Name Primer Sequence
LC3A pCoofy1 fw aagttctgttccaggggcccatgccctcagaccggc
LC3A pCoofy1 rv ccccagaacatcaggttaatggcgtcagccgaaggtttcctggg
LC3B pCoofy1 fw aagttctgttccaggggcccatgccgtcggagaagaccttc
LC3B pCoofy1 rv ccccagaacatcaggttaatggcgttacccgaacgtctcctggg
GABARAP pCoofy1 fw aagttctgttccaggggcccatgaagttcgtgtacaaagaagagcatcc
GABARAP pCoofy1 rv ccccagaacatcaggttaatggcgtcaaccgtagacactttcgtcactgtagg
GATE-16 pCoofy1 fw aagttctgttccaggggcccatgaagtggatgttcaaggaggacc
GATE-16 pCoofy1 rv ccccagaacatcaggttaatggcgtcagccaaaagtgttctctccgc
LC3A CysIns fw gttccaggggccctgcatgccctcagaccg
LC3A CysIns rv cggtctgagggcatgcagggcccctggaac
LC3B CysIns fw gttccaggggccctgcatgccgtcggagaag
LC3B CysIns rv cttctccgacggcatgcagggcccctggaac
GABARAP CysIns fw gttccaggggccctgcatgaagttcgtgtacaaagaag
GABARAP CysIns rv cttctttgtacacgaacttcatgcagggcccctggaac
GATE-16 CysIns fw gttccaggggccctgcatgaagtggatgttcaagg
GATE-16 CysIns rv ccttgaacatccacttcatgcagggcccctggaac
Atg3 Hs pCoofy1 fw aagttctgttccaggggcccatgcagaatgtgattaatactgtgaagggaaagg
Atg3 Hs pCoofy1 rv ccccagaacatcaggttaatggcgttacattgtgaagtgtcttgtgtagtcatattctattgttgg
Atg10 ins ag74/75 fw agaattcattaaacattcacaacagataggtgatagttgggaatggag
Atg10 ins ag74/75 rv ctccattcccaactatcacctatctgttgtgaatgtttaatgaattct
Atg10 mut t635c fw ctgagttatgccaaagcaacgtctcaggatgaacgaa
Atg10 mut t635c rv ttcgttcatcctgagacgttgctttggcataactcag
Atg10 mut a659c fw tctcaggatgaacgaaatgtcccttaacaagattcttctattgag
Atg10 mut a659c rv ctcaatagaagaatcttgttaagggacatttcgttcatcctgaga
Atg5 Hs pCoofy1 fw aagttctgttccaggggcccatgacagatgacaaagatgtgcttcgagatg
Atg5 Hs pCoofy1 rv ccccagaacatcaggttaatggcgtcaatctgttggctgtgggatgatactaatatg
Atg7 Hs pCoofy1 fw aagttctgttccaggggcccatggcggcagctacgg
Atg7 Hs pCoofy1 rv ccccagaacatcaggttaatggcgtcagatggtctcatcatcgctcatg
Atg7 pCTEV rv gccctgaaaatacaggttttcgatggtctcatcatcgctcatg
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Atg10 H pCoofy1 fw aagttctgttccaggggcccatggaagaagatgagttcattggagaaaaaacattcc
Atg10 H pCoofy1 rv ccccagaacatcaggttaatggcgttaagggacatttcgttcatcctgagacg
Atg12 Hs pCoofy1 fw aagttctgttccaggggcccatgactagccgggaacaccaag
Atg12 Hs pCoofy1 rv ccccagaacatcaggttaatggcgtcatccccacgcctgag
Table 2.15.: Primers for In-Fusion cloning of ATG7, ATG10, ATG12 and ATG5
into pST39. (First part) Green marks homology sequences to either pST39 or the
preceding protein. Blue and violet mark the translational enhancer and the Shine-
Dalgarno sequence, respectively. Start and stop codons are marked in red and the His6
tag in orange. (Second part) Primers for further modifications of pST39. Additional
sequence of ATG7 isoform 1 marked in violet, cysteine codon for fluorescent labeling of
Atg12 marked in orange.
Primer Name Primer Sequence
pST39 lineralize rv gaattcactggccgtcgttttacagg
pST39 lineralize fw ggtaccagcggataacaatttcacatc
InFus Atg7 fw
acggccagtgaattcaataattttgtttaactttaagaaggagatatacat
atggcggcagctacgggg
InFus Atg7 rv tcagatggtctcatcatcgctcatgtc
InFus Atg10 fw
gatgagaccatctgaaataattttgtttaactttaagaaggagatatacat
atggaagaagatgagttcattggag
InFus Atg10 rv ttaagggacatttcgttcatcctg
InFus Atg12 fw
cgaaatgtcccttaaaataattttgtttaactttaagaaggagatatacat
atgactagccgggaacaccaag
InFus Atg12 rv ttatccgctggtacctcatccccacgcctgagac
pST39 lineralize2 rv tcatccccacgcctgagac
InFus Atg5 His fw
caggcgtggggatgaaataattttgtttaactttaagaaggagatatacat
atgggcagcagccatcaccatcaccatcacggcagcatgacagatgacaaagatgtgcttc
InFus Atg5 rv tcaatctgttggctgtggg
InFus Atg16L1 fw
cagccaacagattgaaataattttgtttaactttaagaaggagatatacat
atgtcgtcgggcctccgc
InFus Atg16L1 rv ttatccgctggtacctcagtactgtgcccacagcacagct
InFus TECPR1 fw
cagccaacagattgaaataattttgtttaactttaagaaggagatatacat
atgcccaactcagtgctgtggg
InFus TECPR1 rv ttatccgctggtacctcagcagcagacggggcc
Atg7 IF1 lin fw
ggcatttgacaaatgtacagcttgttcttccaaa
gttcttgatcaatatgaacgagaaggatttaacttcc
Atg7 IF1 lin rv
ctgtacatttgtcaaatgccaggctgacgggaagg
acattatcaaaccgtgaaagaaatccccggatctggtgaggcacaagcccaag
pST Atg10 lin rv aattgttatccgctggtaccttaagggacatttcgttcatcctg
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pST Atg5 lin Rv
acatctttgtcatctgtcatatgtatatctccttcttaaagttaaa
caaaattatttcatccccacgcc
pST Atg5 lin Fw atgacagatgacaaagatgtgcttcg
pST Atg12 lin Rv
tggtgatggtgatgtttcatatgtatatctccttcttaaagttaaaca
aaattattttaagggacatttcg
pST Atg12 VL lin Fw aagttctgttccaggggcccatggcggaggagccgcagtc
His-MBP-Fw atgaaacatcaccatcaccatcacccc
pST His10 lin rv acccgcggagtgatggtgatggtgatggtgatggtgatgtttcatatg
pST His10 lin fw catcaccatcactccgcgggtctggaagttctgttccagggg
ATG12 CysIns fw gttccaggggccctgcatggcggaggagc
ATG12 CysIns rv gctcctccgccatgcagggcccctggaac
Table 2.17.: Primers for ATG16L1 and TECPR cloning. (First part) Primers
for site-directed mutagenesis of ATG16. Changed bases and additional sequence for
ATG16L1 isoform are marked in green. (Second part) Primers for SLIC cloning
of ATG16. Gene specific sequences are marked in blue. (Third part) Primers for
truncated versions of ATG16L1. Stop codons introduced by site-directed mutagenesis
marked in red. (Fourth part) Primers for TECPR1 cloning.
Primer Name Primer Sequence
Atg16 ins ttag316 fw acaagaaacgtggggagttagctcaactggtgattgac
Atg16 ins ttag316 rv gtcaatcaccagttgagctaactccccacgtttcttgt
Atg16L1 Mut g840a fw cccccaggacaatgtggatactcatcctggttctggtaaag
Atg16L1 Mut g840a rv ctttaccagaaccaggatgagtatccacattgtcctggggg
Atg16L1 IF1 fw
gccatcagcagagcagccactaagcgactctcgcagcctgctggaggcct
tctggattctatcactaatatctttgggagacgctctgtctcttccttccc
Atg16L1 IF1 rv
gggaaggaagagacagagcgtctcccaaagatattagtgatagaatccag
aaggcctccagcaggctgcgagagtcgcttagtggctgctctgctgatggc
Atg16L1 pCoofy1 fw aagttctgttccaggggcccatgtcgtcgggcctcc
Atg16L1 pCoofy1 rv ccccagaacatcaggttaatggcgtcagtactgtgcccacagc
Atg16L1 pCTEV rv gccctgaaaatacaggttttcgtactgtgcccacagcacag
ATG16 pC1 DltWD fw tgacgccattaacctgatgttctgg
ATG16 pC1 DltWD rv gaacatcaggttaatggcgtcaatcgaagacacacaaggcagtagctgg
ATG16 pC37 DltWD rv ccctgaaaatacaggttttcatcgaagacacacaaggcagtagctgg
ATG16 DltWD Stop fw gccttgtgtgtcttcgattgacatgatggggaagtcaac
ATG16 DltWD Stop rv gttgacttccccatcatgtcaatcgaagacacacaaggc
ATG16 1-43 Stop fw ctgcagtataacaaattgctgtaaaagtcagatcttcattcagtg
ATG16 1-43 Stop rv cactgaatgaagatctgacttttacagcaatttgttatactgcag
16 2-10 Del pST39 fw ctttaagaaggagatatacatatgccccgctggaagcgccac
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16 2-10 Del pST39 rv gtggcgcttccagcggggcatatgtatatctccttcttaaag
16 1-10 Del pC fw gaagttctgttccaggggcccccccgctggaagcgccac
16 1-10 Del pC rv gtggcgcttccagcgggggggcccctggaacagaacttc
TECPR1 pCoofy1 fw aagttctgttccaggggcccatgcccaactcagtgctgtg
TECPR1 pCoofy1 rv ccccagaacatcaggttaatggcgtcagcagcagacgggg
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Results
3.1. Characterization of the yeast Atg8-scaffold
by AFM
The decoration of autophagosomal membranes with Atg8 conjugated to phospha-
tidylethanolamine (PE) is the hallmark of macroautophagy. Atg8 serves as cargo
adaptor on the inner membrane of the growing phagophore, but so far its purpose
on the outer membrane remained elusive. Previous studies in our lab led to the
hypothesis that Atg8 and Atg12–Atg5-Atg16, the two Ubiquitin like (UBL) systems
in yeast, are part of a new protein scaffold that forms on emerging autophagosomes.
This hypothesis was based on in vitro experiments, in which the lipidation reaction
of Atg8 to PE has been reconstituted on giant unilamellar vesicles (GUVs) with
fluorescently labeled proteins. However, a direct visualization of the proposed scaffold
was needed to validate this hypothesis. Due to technical difficulties of imaging a
protein scaffold on liposomes with electron microscopy, Atomic force microscopy
(AFM) was considered suitable owing to its high resolution in combination with
imaging under physiological conditions.
Since only flat membranes can be imaged with AFM, the first aim was to recon-
stitute the lipidation reaction of Atg8 on flat model membranes, namely supported
lipid bilayers (SLBs). A frequently used sample support for Atomic Force Microscopy
is the mineral mica, since this sheet silicate is extremely flat and clean when freshly
cleaved. SLBs could be reconstituted on mica, however, the conjugation reaction of
Atg8 to PE destroyed the membrane (Fig. 3.1). Therefore, different supports were
tested: first, by chemically cross-linking silane to the mica surface, the lipidation was
reconstituted without destruction of the membrane. This approach preserved the flat-
ness of the support, but was technically challenging due to a long preparation and low
reproducibility of the lipidation reaction. Another support used was plasma-cleaned
glass. Glass is rougher compared to mica, but the preparation was faster and the
lipidation reaction did not destroy the membrane. Thus, the lipidation of Atg8 could
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be successfully reconstituted on SLBs using two types of support: glass and silanized
mica. For a successful reconstitution of this reaction, all participating proteins had
to be incubated together with SLBs, to conjugate Atg8 to PE in the membrane.
The final protein ratios used were 6:2:2:1:1 for Atg8:Atg7:Atg3:Atg12–Atg5:Atg16,
together with ATP (for concentrations see chapter 2.2, p. 24).
Figure 3.1.: Confocal microscopy image of supported lipid bilayer deposited on
freshly-cleaved mica, labeled with Lissamine-Rhodamine in red. The bilayer is intact
before the addition of proteins (left) but is destroyed upon addition of the yeast UBL
proteins (displayed after 1 minute (middle) and 20 minutes (right), Atg8 labeled with
Alexa488 in green). Atg8 binds directly to mica and displaces the bilayer from the
support.
Combining AFM with confocal microscopy was an essential prerequisite for success-
ful experiments. First, the lipidation reaction was monitored by confocal microscopy,
and only if the membrane was lipidated with fluorescent Atg8 molecules, further
experiments were performed with AFM. To control for a successful reaction after
incubation of the proteins, the membrane was washed thoroughly to remove any
soluble or unbound proteins from the membrane. Previous Fluorescence Recovery
After Photobleaching (FRAP) experiments on GUVs demonstrated, that Atg8 is
mobile when conjugated to the membrane with Atg12–Atg5, but immobile with
Atg12–Atg5-Atg16. Therefore, similar FRAP experiments were carried out on SLBs
to test whether the mobility of Atg8 can be reproduced on SLBs. In the absence
of Atg16, Atg8–PE slowly recovers, indicating lateral mobility of Atg8–PE on the
membrane (Fig. 3.2). The very slow recovery on SLBs compared to free-standing
membranes has been reported before [Sonnleitner et al. 1999]. In the presence of
Atg16, no recovery is visible even after 45 minutes of imaging. This is in agreement
with previous results obtained on GUVs, where no fluorescent recovery of Atg8 or
Atg12–Atg5-Atg16 was detectable. These experiments demonstrated that the lipida-
tion reaction was successfully reconstituted on SLBs and similar results compared to
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GUVs can be obtained on flat model membranes.
Figure 3.2.: Lipidation reaction of Atg8 (labeled with Alexa488 in green) on supported
lipid bilayers (SLBs, containing Lissamine-Rhodamine-PE in red) on glass. A quadratic
area was bleached on the SLB (dark square). These FRAP experiments reveal that
Atg8–PE fluorescence recovers in the absence of Atg16 (left side), whereas in the
presence of Atg16 no recovery is visible, even after 45 minutes (right side).
After the verification that experiments on SLBs yielded comparable results to
GUVs, AFM was performed on Atg8-lipidated membranes. Fluorescence microscopy
showed that the proteins of the UBL systems, namely Atg8 and Atg12–Atg5-Atg16,
formed an immobile protein structure on membranes. Yet, how the proteins were
structurally organized on a nanoscopic scale needed to be investigated. This was
analyzed by AFM imaging of Atg8-lipidated SLBs with Atg12–Atg5 or Atg12–Atg5-
Atg16.
The Atomic Force Microscope can be operated in different modes. Two major
operation forms exist for imaging the topology of samples. In scanning mode, the
cantilever is in constant contact to the sample and scans its surface with steady
force that is controlled by a feedback loop according to the topology. This mode is
well suited for hard and stable samples, because it allows for high resolution and
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rapid image acquisition without deforming the sample. In tapping mode, the second
mode of operation, the tip scans the sample while oscillating with a preset frequency,
which is also controlled by a feedback loop. Thus, the tip is not constantly in contact
with the sample and therefore minimizes deformation of the sample, but imaging
acquisition is slower compared to scanning mode and oscillation frequency needs to
be adjusted regularly. Here, the Atomic Force Microscope was operated in tapping
mode, because proteins on top of a bilayer in physiological conditions constitute a
very soft and fragile sample. Imaging these samples in scanning mode would cause
distortions and disruption of delicate protein connections.
Bigger protein aggregates were detected in all samples (~100 nm in diameter and
>20 nm in height, bright spots in Fig. 3.3). In the absence of Atg16, only small
particles with no obvious structure were detectable (Fig. 3.3, A). These particles
represent most likely Atg8 proteins or Atg8–PE/Atg12–Atg5 complexes, which are
linked to PE but freely mobile within the membrane. They were hardly imageable
due to their lateral mobility. The stripy appearance in the image stems from particles,
which were stuck to the tip and dragged along by the cantilever during the horizontal
scan (Fig. 3.3, A, right).
The appearance changed drastically, when also Atg16 was present in addition to
Atg12–Atg5. No individual particles could be detected, rather a continuous protein
layer formed on top of the SLB (Fig. 3.3, B, left). This protein layer was organized in a
meshwork-like structure, which becomes even more pronounced when the topological
data was averaged and filtered (Fig. 3.3, B, right). Therefore, Atg16 immobilizes and
organizes Atg8–PE/Atg12–Atg5 complexes into a two-dimensional protein layer.
By using plasma-cleaned glass instead of silanized mica as support, it was possible
to reduce the movement of the Atg8 particles in the absence of Atg16 considerably
(Fig. 3.4). Here, regular protein aggregates were forming, consisting of Atg8 and
Atg12–Atg5. Presumably the higher surface roughness of glass compared to mica
hampered the diffusion of the protein aggregates and enabled a closer examination.
Measuring and cross-sectioning of obtained images yielded a diameter of these
particles of 50 ± 10 nm and a height of 6 ± 1 nm (Fig. 3.5, upper part). However,
the diameter of Atg8 and Atg12–Atg5 is only ~3 nm and ~6 x 4 nm2, respectively,
according to PDB entries 3VXW and 3W1S. Therefore the particles are too big
to represent individual Atg8–PE conjugates or one Atg8–PE/Atg12–Atg5 complex.
Taking the lateral dimensions of the cantilever into account, as well as Brownian
motion of the particles, the size of the particles corresponds to two but not more
than four Atg8–PE/Atg12–Atg5 complexes. Interestingly, the particles show a
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Figure 3.3.: Conjugated Atg8 to SLBs deposited on silanized mica and imaged with
atomic force microscopy, in the absence or presence of Atg16. (A) Control reaction
with Atg12–Atg5, shown in different scales, line-fitted but otherwise unmodified. White
spots represent protein aggregates >15 nm in height. (B) In the presence of Atg16, the
autophagic membrane scaffold forms, shown here in an area of 1 µm2 (upper panel) and
0,25 µm2 (lower panel). On the left side line-fitted but otherwise unmodified images
are displayed, on the right side the corresponding data was averaged, filtered, and
displayed in 3D projection for better visualization. A lateral meshwork-like structure
of the scaffold becomes apparent.
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very homogeneous size distribution, which demonstrates that Atg8–PE/Atg12–Atg5
associates into well-defined oligomeric complexes on SLBs.
Figure 3.4.: Conjugated Atg8 to SLBs deposited on glass, in the absence (upper
part) or presence of Atg16 (lower part), imaged with atomic force microscopy. Images
are line fitted but otherwise unmodified. Atg8–PE/Atg12–Atg5 complexes are less
mobile on SLBs with plasma-cleaned glass as support compared to mica. They form
homogeneous aggregates, shown at different magnifications (top part). A similar
continuous protein layer is observed on plasma-cleaned glass compared to mica, which
forms from nano- to microscopic scale (bottom part).
Atg8 conjugation and scaffold formation occur sequentially and diffusion of Atg8–
PE might facilitate assembly into more regular scaffolds. Therefore, presumably
due to the restricted mobility of Atg8–PE on glass, the protein scaffold did not
form as regularly as compared to the one on mica (compare Fig 3.4 with Fig. 3.3).
Nevertheless, the scaffold could form across a wide size range, from 0.5 µm x 0.5µm
to 4.0 µm x 4.0 µm (Fig. 3.4, lower part), demonstrating that the immobility observed
in FRAP experiments on GUVs or SLBs indeed stems from a protein layer formed
at the nanoscopic scale. It could be observed that the scaffold covered almost the
whole SLB, yet sometimes membrane areas could be detected which were devoid of
any protein (Fig. 3.5, height image lower part). These ‘holes’ in the scaffold made
it possible to determine the height of this protein layer (Fig. 3.5, cross section and
height distribution). The observed height of the scaffold was 8 ± 2 nm, compared
to 6 ± 1 nm for Atg8–PE/Atg12–Atg5 complexes. The crystal structure of Atg16
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Figure 3.5.: Height quantification of similar images as in Fig. 3.4, on glass as support.
Membrane parts are shown in black. The white dashed line in the height images
indicates the cross section shown in the middle panels. The histograms in the right
panels visualize the relative height distribution of the whole height image (membrane
height was set to 0, bin size = 0,5 nm).
revealed, that the coiled-coil domain of Atg16 has a length of 11 nm [Fujioka et al.
2010]. Therefore, the height difference of only 2 nm for the scaffold measured by AFM
compared to Atg8–PE/Atg12–Atg5 complexes is in agreement with a model, that
Atg16 intercalates in between Atg8–PE/Atg12–Atg5 complexes horizontally on the
membrane and structures them into a protein layer with meshwork-like architecture.
The crystal structure also revealed a stretch of exposed hydrophobic residues in
Atg16, which stabilized a crystal contact between two antiparallel Atg16 dimers
[Fujioka et al. 2010]. Therefore, the hypothesis was developed that Atg16 forms
antiparallel tetramers to cross-link Atg8–PE/Atg12–Atg5 complexes. This hypothesis
could be fortified by determining the edge length of the scaffold to be 17 ± 4 nm
(Fig 3.6), which corresponds to the current estimate of the length of an Atg16
coiled-coil tetramer. In conclusion, AFM imaging proved, that Atg8 together with
Atg12–Atg5-Atg16 forms a so far undescribed protein scaffold on membranes in vitro.
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Figure 3.6.: Size measurements determined by manual estimation of reconstituted
lipidation experiments, based on line-fitted but otherwise unmodified AFM images. (A)
Diameter estimation of Atg12–Atg5/Atg8–PE oligomers on SLB on glass. No Atg16
was used for the lipidation reconstitution. (B) Edge length estimation of autophagic
membrane scaffold on SLB on silanized mica. Here, Atg16 was added to the protein
mixture.
54
Results 3.2. Electron microscopy of yeast cells
3.2. Electron microscopy of yeast cells
In yeast, it is still unclear how the lipidation machinery is recruited to the autophago-
somal membrane. In mammals, WIPI2b (WD-repreat PtdIns(3)P effector protein
2b) acts upstream of LC3 conjugation by directly binding ATG16L1 and therefore
recruiting ATG12–ATG5-ATG16L1 to the autophagosomal membrane [Dooley et al.
2014]. However, if the yeast homolog of WIPI2, Atg18, has a similar upstream func-
tion in Atg8 lipidation remains a matter of debate [Suzuki et al. 2007]. Furthermore,
it was recently demonstrated that Atg21, a closely related protein to Atg18, directly
interacts with Atg16 and therefore defines the conjugation site of Atg8 in vegetative
conditions [Juris et al. 2015]. To decipher the individual roles of Atg18 and Atg21
during starvation induced autophagy, the two genes were knocked out and transmis-
sion electron microscopy was performed of whole yeast cells under non-starvation
conditions (Fig. A.8, p. 98) and after four hours of nitrogen starvation (Fig. 3.7).
This set of experiments was performed to support the research of B. Hofmann, who
provided the yeast strains. To investigate the impact of the knocked out protein
directly on autophagosome formation, the cells were carrying another knockout, the
gene for peptidase Pep4. Thereby autophagosomes are not degraded, but stay in the
vacuole as autophagic bodies and their size and number can be investigated.
In starved ‘wildtype’ cells, which only carried the pep4 knockout, the accumulation
of autophagic bodies is clearly visible (white arrows in Fig. 3.7, WT). Similarly, also
autophagic bodies can be observed for Atg21 knockout, however, they are smaller
and fewer compared to WT autophagic bodies (white arrow in Fig. 3.7, ΔAtg21).
This result is in line with the finding, that Atg21 recruits Atg12–Atg5-Atg16 to the
autophagosomal membrane and therefore enhances Atg8 conjugation [Juris et al.
2015]. In Atg18 knockout cells, occasionally granular vacuoles were observed, but no
autophagic bodies could be detected (arrow head and arrow in Fig. 3.7, ΔAtg18).
Therefore, Atg18 is essential for autophagosome formation, but since the phenotype
differs compared to Atg21, the two proteins seem to have diverging functions. To
test whether high levels of Atg21 can compensate for the loss of Atg18, cells with
a double knockout of Atg18 and Atg21 were imaged, which carry an additional
vector for overexpression of Atg21. Here again, no autophagic bodies could be
observed. Therefore even an overexpression of Atg21 cannot compensate for the loss
of Atg18. This result further demonstrates, that Atg18 and Atg21 act differently
in autophagosome formation. Notably, the vacuoles showed a pronounced granular
phenotype. These light structures, that do not contain electron dense material,
are either lipid droplets, or correspond to intra-luminal vesicles of multi-vesicular
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pathways (Fig. 3.7, ΔAtg18, ΔAtg21, Atg21oe).
Figure 3.7.: Transmission electron microscopy images of whole yeast cells with pep4
deletion after 4 hour starvation. Pep4 deletion leads to accumulation of autophagic
bodies in the vacuole. (WT) Wildtype cells, carrying only the pep4 deletion, show a
strong accumulation of autophagic bodies in the vacuole (white arrows). (ΔAtg21) In
vacuoles of cells with an Atg21 knockout smaller and fewer autophagic bodies accumu-
late in the vacuole (white arrow). (ΔAtg18) Cells knocked out for Atg18 do not show
any autophagic bodies (arrow). Occasionally, the vacuole has a granular appearance
(arrow head). (ΔAtg18, ΔAtg21, Atg21oe) Cells with an overexpression of Atg21
cannot compensate for loss of Atg18, since no autophagic bodies accumulate in the
vacuoles. The granular phenotype of the vacuole corresponds to either lipid droplets
that were taken up and partially degraded, or intra-luminal vesicles of multi-vesicular
bodies. V vacuole, N nucleus, L lipid droplet, scale bar 1 µm.
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3.3.1. Expression and purification of human ATG8 proteins
The two interconnected Ub-like conjugation systems, which coordinate lipidation of
Atg8 in yeast, are highly conserved in humans. However, the human UBL systems
are more complex, with at least seven Atg8 homologs (hATG8s) and different ATG12–
ATG5 interaction partners. Interestingly, most of the homologs are expressed in all
tissues, arguing that evolution-driven diversification and specialization occurred in
response to a change from single cell to multicellular organisms. This implies, that
hATG8s demonstrate varying functions during autophagosome formation. Therefore,
the identification of a new protein scaffold, that might be present on autophagosomes
in yeast, raised two questions: (1) Is a similar scaffold existent in humans? And (2)
if so, which of the human ATG proteins is involved as building block? To answer
these questions and also to elucidate the possible different functions of hATG8s,
it was necessary to purify the “toolbox” of human UBL proteins, namely different
Atg8 homologs, but also ATG7, ATG3, ATG12–ATG5, and ATG16L1. Four hATG8
proteins were chosen, that are LC3A, LC3B, GABARAP, and GATE-16. These four
hATG8s represent the two subfamilies of Atg8 homologs: LC3A and LC3B for the
subfamily LC3, and GABARAP and GATE-16 for the subfamily GABARAP.
All cDNA clones for human ATG proteins were picked from the in-house ImaGenes
cDNA Library. For a successful in vitro reconstitution of the lipidation reaction,
hATG8 cDNAs were cloned without the C-terminal amino acid(s), which are cleaved
off in vivo by the protease ATG4. Also, a cysteine was inserted at the N-terminus
of each hATG8 for labeling with fluorescent dyes (see chapter 2.4, p. 30). These
modified proteins are referred to their original names for simplicity. ATG proteins
were cloned in expression vectors with different purification tags, provided by the
Biochemistry Core Facility (MPIB, Martinsried). hATG8s were successfully expressed
in E.coli from the vector pCoofy1, in which a His6-tag is fused to the N-terminus
of the recombinant protein. Expression over night at 18°C or for three hours
at 37°C was equally successful (Fig. 3.8). hATG8s were subjected to a two-step
purification scheme, first a Ni-NTA affinity chromatography in batch, and second a
size exclusion chromatography to remove further impurities and rebuffer them. After
affinity chromatography, the proteins were digested by GST-PreScission protease
for one hour at room temperature. Correct mass was verified by mass spectrometry
(Fig. 3.9). GST-PreScission protease was chosen over His-PreScission due to its larger
size and therefore to avoid a co-purification during size-exclusion chromatography
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Figure 3.8.: Expression and purification of human ATG8 proteins with used expression
vector and expression conditions. From top to bottom: LC3A (14.4 kDa), LC3B
(14.4 Da), GABARAP (14.1 kDa), GATE-16 (13.8 kDa). (Left panel) Samples
from expression and purification steps were run on 15% SDS-PAGE gels. Left from the
protein marker different steps of affinity chromatography are displayed, on the right
fractions from size exclusion chromatography (SEC). The double band for GABARAP
and GATE-16 indicates partial cleavage of the His6-tag. (Right panel) SEC profile
from a Superdex 75 column. ni - not induced sample; ind - induced sample; p -
pellet (insoluble fraction); sf - soluble fraction; E1, E2 - elution fractions of Ni-batch
purification; I - input (for SEC); M - protein marker in kDa; A4-C6 - SEC fractions,
as indicated in the respective profile on the right.
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Figure 3.9.: Mass spectra of purified hATG8s, corresponding to the proteins in Fig. 3.8.
(A-D) The calculated masses of LC3A (14382 Da), LC3B (14386 Da), GABARAP
(14061 Da), and GATE-16 (13777 Da) could be detected. In case of LC3A and LC3B, a
small portion of the purified protein was existent as dimer (small peak on the right in
A and B). GABARAP and GATE-16 mass profiles show a large portion of uncleaved
protein (peak with higher mass in C and D).
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Figure 3.10.: Expression, purification, and mass spectrometry of human ATG3
(36.0 kDa) from pCoofy1, at 18°C over night. (A) Samples from expression and
purification steps in 15% SDS-PAGE gels. Left from the protein marker different steps
of affinity chromatography are displayed, on the right fractions from size exclusion
chromatography (SEC). (B) SEC profile from a Superdex 75 column. (C) Mass
spectrometry yielded the correct size of 36017 Da for human ATG3. ni - not induced
sample; ind - induced sample; p - pellet (insoluble fraction); sf - soluble fraction; E1, E2
- elution fractions of Ni-batch purification; A - after PreScission digest; M - protein
marker in kDa; A5-A12 - SEC fractions, as indicated in the respective profile in B.
(His-PreScission: 21.7 kDa, GST-PreScission: 46.3 kDa). When only partial cleavage
of the His6-tag was observed (GABARAP and GATE-16 in Fig. 3.8, Fig. 3.9, C and
D), the proteins were cleaved again and their successful digestion was monitored by
SDS-PAGE. The yield of purified hATG8s ranged from 3.7 to 5 mg protein per liter
bacterial cell culture.
3.3.2. Expression and purification of ATG3
Before hATG8 is conjugated to PE, it is activated by ATG7 and then transferred to
ATG3. ATG3 was cloned in the vector pCoofy1, containing an N-terminal His6-tag,
and successfully expressed in E. coli at 18°C over night (Fig. 3.10). After affinity
chromatography with Ni-NTA, the recombinant protein was subjected to PreScission
protease digestion at room temperature for 45 minutes. To remove further impurities
and rebuffer the protein, size exclusion chromatography with a Superdex 75 column
was performed. The correct mass of ATG3 was verified by mass spectrometry
(Fig. 3.10, C). The yield of purified protein was 2.4 mg per liter bacterial cell culture.
3.3.3. Expression and purification of ATG12–ATG5
Atg12–Atg5 catalyzes the conjugation of Atg8 to PE as the E3-like enzyme. In yeast,
Atg16 is not required for the lipidation reaction per se, only for the formation of
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Figure 3.11.: Test expression samples of human ATG12–ATG5 (47.8 kDa) from pST39
in E. coli over night at 18°C with ATG7 isoform 1 and His6-tagged ATG5. Samples
marked in black are from a vector containing ATG7, ATG10, ATG12, and ATG5, and
either ATG16 (blue) or TECPR1 (violet). (A) 12 % SDS-PAGE gel, with majority
of pulled down protein being ATG5. (B) Western Blot with ATG12 antibody of the
same samples as in A. Faint bands can be detected for ATG12 alone, but majority
exists in conjugate form. Due to its conjugate nature, ATG12–ATG5 runs at a higher
position than is expected from its calculated weight. ni - not induced sample; in -
induced sample; p - pellet (insoluble fraction); sf - soluble fraction; pd - pull down.
the autophagic scaffold. Therefore, the recombinant expression of ATG12–ATG5
was essential to achieve successful lipidation of hATG8s in vitro. The challenge for
the recombinant production of ATG12–ATG5 was the reconstitution of the whole
enzymatic cascade required to covalently link ATG12, an UBL protein, to its sole
target ATG5 (see Fig. 1.2). Two main strategies were followed in parallel to accom-
plish production of ATG12–ATG5: (1) purification of the individual components,
ATG7, ATG10, ATG12, and ATG5 to achieve conjugation of ATG12 to ATG5 in
vitro, and (2), production of all components in situ in E. coli, so that the completed
ATG12–ATG5 conjugate can be purified from bacterial cell lysate.
Following the first strategy, expression of the individual components, major dif-
ficulties were encountered. ATG12 possesses an N-terminal disordered region that
comprises roughly one third of the protein (based on a prediction for protein crys-
tallizability with XtalPred 1) and ATG12 expression, even as fusion protein for
stabilization, remained unsuccessful due to degradation (Fig. A.1, A, p. 93). Addition-
ally, the expression of ATG7 in E. coli did not yield the desired protein (chapter 3.3.4,
Fig. A.1, B, p. 93).
It was shown previously in our lab that the second strategy proved successful for
yeast Atg12–Atg5, which is why a similar cloning strategy for human ATG12–ATG5
was pursued. To achieve a simultaneous expression of ATG7, ATG10, ATG12, and
ATG5, the corresponding cDNAs were cloned into a vector suitable for polycistronic
1http://ffas.burnham.org/XtalPred-cgi/xtal.pl
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Figure 3.12.: Expression and purification of human ATG12–ATG5 (47.8 kDa) from
pST39 in E. coli over night at 18°C with His10-tagged ATG12. (A) 10% SDS-PAGE
gel with samples from affinity (left from marker) and size exclusion chromatography
(right from marker) purification steps. (B) SEC profile of ATG12–ATG5 from a
Superdex 200 column. (C) Mass spectrometry confirmed that ATG12–ATG5 (47800 Da)
was successfully formed and purified. p - pellet (insoluble fraction); sf - soluble fraction;
E1, E2 - elution fractions of Ni-batch purification; I - input for SEC; M - protein marker
in kDa; A6-C8 - SEC fractions, as indicated in the respective profile on the right.
expression, namely pST39 [Tan 2001], and ATG5 was tagged with a His6-tag to
purify the conjugate. Further, the cDNAs of ATG16 or TECPR1 were cloned into
the vector to possibly stabilize the conjugate.
Two isoforms of ATG7 exist in humans. First, isoform 2 was tested, which
corresponded to the cDNA provided by the cDNA library for ATG7. However, no
ATG12–ATG5 production could be detected, instead ATG5 was stably expressed
and purified (Fig. A.1, C, p. 93). When the cDNA of ATG7 isoform 2 was exchanged
for the cDNA of isoform 1 by mutagenesis, the ATG12–ATG5 conjugate could be
detected by Western Blotting (Fig 3.11, B). Test expressions however showed, that
more unconjugated ATG5 was purified compared to ATG12–ATG5, possibly due to
the instability of ATG12 (Fig 3.11, A).
In order to stabilize ATG12 and to purify mainly the conjugate and not uncon-
jugated ATG5, the N-terminal affinity His6-tag was exchanged from ATG5 to an
N-terminal His10-tag on ATG12, and Maltose-binding protein (MBP) was cloned
in between His10-tag and ATG12 to improve solubility. This strategy allowed for
the purification of ATG12–ATG5, but in these samples MBP was co-purified due to
insufficient separation on the SEC column. To improve purity, the coding sequence
of MBP was removed from the vector and His10-ATG12 was co-expressed with ATG5,
ATG10, and ATG7, which generated the recombinant conjugate in high purity. The
average yield was 0.5 mg protein per liter bacterial cell culture (Fig. 3.12, A and B).
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Figure 3.13.: Expression, purification and mass spectrometry of recombinantly
expressed human ATG7 (78.1 kDa) from pCoofy27 in SF9 insect cells. (A) 10%
SDS-PAGE gel with samples from affinity (left from marker) and size exclusion chro-
matography (right from marker) purification steps. (B) SEC profile of ATG7 from a
Superdex 200 column. (C) The detected mass of 78195 Da corresponds to an increase of
81 Da compared to the theoretical mass of 78114 Da, and represents a posttranslational
phosphorylation. (D) After treating hATG7 with phosphatase (CIP), the calculated
mass of 78114 Da is detected. p - pellet (insoluble fraction); sf - soluble fraction; E1, E2
- elution fractions of Ni-batch purification; I - input for SEC; M - protein marker in
kDa; A5-B10 - SEC fractions, as indicated in the respective profile in B.
For labeling, an N-terminal cysteine was added to ATG12 (final vector in Fig. 2.2,
p. 32). The final purification scheme consisted of two steps, first affinity chromatog-
raphy with Ni-NTA raisin, after which the His10-tag was cleaved off by PreScission
protease, and second SEC on a Superdex 200 column. Mass spectrometry analysis
detected the exact theoretical weight of ATG12–ATG5 (47.8 kDa, Fig. 3.12, C).
3.3.4. Expression and purification of ATG7
ATG7 is the E1-like enzyme in the activation of ATG12 and hATG8s, and the first
protein of the enzymatic cascade for lipidation of hATG8. Therefore its expression
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and purification was indispensable for a successful reconstitution of the human
lipidation machinery. Test expressions of ATG12–ATG5 demonstrated, that only
isoform 1, the canonical form of ATG7, is enzymatically active for conjugating ATG12
to ATG5 (Fig. 3.11). Therefore, all expressions and purifications were executed with
ATG7 isoform 1. Even though test expressions with different tags for purification
yielded promising results in E.coli, large scale expression in bacteria remained
unsuccessful (one example is displayed in Fig. A.1, B, p. 93). Consequently, the cDNA
was cloned into insect cell expression vectors, that contained different affinity tags.
Test expressions with SF9 and H5 insect cells, as well as different concentrations of
Baculovirus-infected insect cells (BIICs) were carried out by the Biochemistry Core
Facility (MPIB). Best expression was achieved from either pCoofy27, a vector adding
an N-terminal His7-tag to the recombinant protein, or from pCoofy28, a vector
adding an N-terminal Glutathione S-transferase (GST). Both samples were obtained
from SF9 cells with BIICs used in the concentration of 1:4000 (Fig. A.2, p. 94). These
expression conditions were used again in a mid-scale expression and a pull-down
experiment was performed with the samples. Here, the yield of recombinant ATG7
was much higher in pCoofy27 compared to pCoofy28 (Fig. A.3, p. 95).
After determining the best expression conditions, large scale expression and purifi-
cation of ATG7 was performed in SF9 insect cells. A two-step purification scheme was
executed, first affinity chromatography with Ni-NTA raisin, after which the His6-tag
was cleaved off by PreScission protease, and second SEC on a Superdex 200 column.
Expressions yielded up to 2.5 mg protein per liter insect cell culture (Fig. 3.13, A
and B). Mass spectrometry confirmed that ATG7 was successfully expressed and
purified. Still, the theoretical mass of 78114 Da could not be detected, instead a
mass of 78195 Da was measured, which corresponds to a change of +81 Da. ATG7
was therefore most likely posttranslationally modified, since this mass change corre-
sponds to a phosphorylation of ATG7 (expected mass gain of 81 Da, Fig. 3.13, C).
To test whether ATG7 was indeed phosphorylated, a sample was incubated with
Calf-intestinal alkaline phosphatase (CIP) and subjected again to mass spectrometry.
The second measurement yielded the calculated mass of 78114 Da, confirming the
phosphorylation of ATG7 (Fig. 3.13, D).
3.3.5. Detection of thioester intermediates
In yeast, Atg8–PE production depends on Atg7 and Atg3, as well as Atg12–Atg5-
Atg16. Previous studies in our lab showed, that in vitro, yeast Atg8 can be conjugated
to large unilamellar vesicles (LUVs) without Atg12–Atg5. However, the lipidation
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Figure 3.14.: Detection of thioester intermediates and possible formation of the
LC3A–PE conjugate. (Left) SDS-PAGE gradient gel for the detection of thioester
intermediates. The proteins of the lipidation reaction were added consecutively to each
other. ATG7–LC3A can be observed from lane 3 on (green arrow) and ATG3–LC3A
from lane 5 on (orange arrow). Phosphatase (CIP) was added to every other reaction
mixture to test if phosphorylation of ATG7 had an effect on intermediate formation.
(Right) Same samples from the left panel were subjected to gel electrophoresis in
an urea gel for detection of LC3A–PE. No LC3A–PE could be detected in the lanes
with added lipids, which should be visible as LC3A double band in urea gels (large
unilamellar vesicles (LUVs) in the last two lanes). Therefore, the last step of the
lipidation reaction was compromised.
of Atg8 to giant unilamellar vesicles (GUVs) requires Atg12–Atg5, presumably
related to the lower membrane curvature, but Atg16 is dispensable. For the human
system, conflicting data existed [Otomo et al. 2013; Nath et al. 2014]. Therefore, the
requirement for different conditions was systematically investigated by setting up
the steps of the lipidation reaction sequentially in vitro. A gradient gel allowed the
detection of thioester intermediates, which form during the enzymatic cascade. Also,
lipidated Atg8 can be detected using Urea-gels [Nakatogawa et al. 2012a]. To see if
the proteins are functional, they were added consecutively in their way of action to
each other. Indeed, all thioester intermediates could be detected (ATG7–LC3A and
ATG3–LC3A, see Fig. 3.14, left panel).
To test if the phosphorylation of ATG7 has an influence on the enzymatic properties
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of ATG7, samples with Calf-intestinal alkaline phosphatase (CIP) were also prepared.
Interestingly, the reaction efficiency with phosphorylated ATG7 was higher compared
to unphosphorylated ATG7, since in samples without CIP no unconjugated LC3A
could be detected, and bands corresponding to LC3A-intermediates were more intense
in samples with phosphorylated ATG7. Therefore, the phosphorylation of ATG7
might be required for full ATG7 activity in vitro and might serve as a regulatory
mechanism in vivo.
No LC3A–PE could be detected (no LC3A double band in urea gel in Fig. 3.14, right
panel). This experiment demonstrated, that the initial steps of the lipidation reaction
work (thioester intermediate formation), but not the last step, the conjugation of
LC3A to PE. A possible explanation for missing lipidation was that ATG16L1 is
required for ATG12–ATG5 to be active, since this was the only component of the
system that was missing.
3.3.6. Expression and purification of ATG16L1 full-length
and truncated forms
Full-length ATG16L1
Efficient conjugation of LC3 to membranes might require ATG16L1, although a high
DOPE-content has been reported to be sufficient for conjugation in the absence
of ATG16L1 [Nath et al. 2014]. Therefore, also the expression of ATG16L1 was
indispensable. After the cloning of ATG16L1 into different expression vectors for
E. coli, test expression results looked promising for expression in bacteria. However,
comparable to ATG7, larger culture volumes did not improve protein yield. Thus,
ATG16L1 was expressed in insect cells. ATG16L1 was cloned into three vectors with
different affinity tags suitable for expression in insect cells. Test expressions with
SF9 and H5 insect cells, as well as different concentrations of Baculovirus-infected
insect cells (BIICs) was carried out by the Biochemistry Core Facility (MPIB). Best
expression was achieved from either pCoofy27, or pCoofy29, which allowed expression
of ATG16L1 as N-terminal His7- or His6-MBP-tagged proteins. Both samples were
obtained from H5 cells with BIICs used in the concentration of 1:1000 (Fig. A.4,
p. 95). These expression conditions were used again in a mid-scale expression and a
pull-down experiment was performed with the samples. Here, the yield of recombinant
MBP-ATG16L1 fusion protein was higher compared to His7-ATG16L1 (Fig. A.5,
p. 96).
Therefore, large scale expression and purification of ATG16L1 was performed in
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Figure 3.15.: Expression, purification and mass spectrometry of full-length ATG16L1
(68.4 kDa) from pCoofy29 in H5 insect cells. (A) 10% SDS-PAGE gel with samples
from affinity (left from marker) and size exclusion chromatography (right from marker)
purification steps. The arrow head points to ATG16L1 band, the lower band in lanes
C7-C10 corresponds to MBP. (B) SEC profile of ATG16L1 from a Superdex 200 column.
The high peak on the right corresponds to MBP. (C) Mass spectrometry profile of
purified full-length ATG16L1. Two masses could be detected: 68419 Da corresponds to
the exact theoretical mass of the protein, and 68495 Da, which corresponds to a mass
increase of 76 Da. This mass increase is equivalent to a β-mercaptoethanol adduct, a
remnant from protein purification that could not be removed. p - pellet (insoluble
fraction); sf - soluble fraction; E1, E2 - elution fractions of Ni-batch purification; I -
input for SEC; M - protein marker in kDa; A3-C10 - SEC fractions, as indicated in
the respective profile on the right.
H5 insect cells from the vector pCoofy29 and a two-step purification protocol was
applied. First affinity chromatography with Ni-NTA raisin was performed, after
which the His7-tag was cleaved off by PreScission protease digestion, followed by
SEC on a Superdex 200 column (Fig. 3.15). A typical SEC elution profile is displayed
in Fig. 3.15, B. Free MBP could be separated after PreScission protease digest from
ATG16L1 by SEC (big peak on the right, Fig. 3.15). Protein identity could be
confirmed by mass spectrometry (Fig. 3.15, C), even though ATG16L1 could not
always be detected by ESI-MS, probably due to insufficient ionization of the protein.
Expression and purification yielded ~0.25 mg of ATG16L1 per liter insect cell culture.
ATG16ΔWD
Yeast Atg16 does not possess a C-terminal WD-domain and it was demonstrated
before that the coiled-coil domain of ATG16L1 is sufficient for autophagy [Mizushima
et al. 2003]. Therefore it was hypothesized that the WD-domain, which targets
ATG16L1 to non-autophagic membranes by binding specific ATG16L1-receptors
[Travassos et al. 2010; Boada-Romero et al. 2013], is also dispensable in the human
UBL-system for the formation of the autophagic scaffold. To test this hypothesis, a
truncated form of ATG16L1, hereafter referred to as ATG16ΔWD, with a missing
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Figure 3.16.: Expression, purification, and mass spectrometry of ATG16ΔWD
(36.9 kDa) from pCoofy4 in E. coli at 18°C over night. (A) 10% SDS-PAGE gel
with samples from affinity (left from marker) and size exclusion chromatography (right
from marker) purification steps. The arrow head points to the ATG16ΔWD band, the
higher band in lanes C6-C10 corresponds to MBP. (B) SEC profile of ATG16L1 from
a Superdex 200 column. The high peak on the right corresponds to MBP. (C) Mass
spectrometry profile of purified ATG16ΔWD. Mainly two masses could be detected:
36871 Da corresponds to the theoretical mass of ATG16ΔWD. A higher intensity was
detected for a protein with a mass of 30662 Da. It is not clear, if this protein is an
impurity or a degradation product of ATG16ΔWD. Also, insufficient ionization, which
were already observed for full-length ATG16L1, could account for the low intensity
measured for ATG16ΔWD. p - pellet (insoluble fraction); sf - soluble fraction; I - input
for SEC; M - protein marker in kDa; A6-C10 - SEC fractions, as indicated in the
respective profile on the right.
WD-domain, was produced. ATG16ΔWD was cloned in different expression vectors
for E. coli and test expression results yielded the most promising expression conditions
with pCoofy4 (MBP as affinity-tag) at 18°C over night. In large scale expression,
ATG16ΔWD was produced and purified (Fig. 3.16, arrow head in A). Even though the
purification did not yield a very pure product (lane A12, Fig. 3.16, A), a corresponding
mass of 36871 Da was detectable (Fig. 3.16, C). However, a second mass of 30662 Da
was more abundant. This mass corresponds to a degradation product of ATG16ΔWD,
lacking the last 59 amino acids from ATG16ΔWD. Insufficient ionization, which
was already observed for full-length ATG16L1, could account for the low amount
of non-degraded ATG16ΔWD detected in mass spectrometry, since only a band
corresponding to a mass of ~37 kDa was visible in ATG16ΔWD containing fractions
(Fig. 3.16, A).
ATG16NT
The coiled-coil domain of ATG16L1 might, in analogy to the yeast system, be required
for scaffold formation. However, without ATG16L1, no lipidation of LC3A has been
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observed (Fig. 3.14). To activate ATG12–ATG5, but prevent formation of scaffolds,
another truncated form of ATG16L1 was produced, lacking both WD and coiled-coil
domains (ATG16NT, residues 11-43). This 43 amino acid long peptide was shown to
bind to ATG5 in the ATG12–ATG5 complex. Additionally, when used together with
ATG12–ATG5, it was sufficient to conjugate LC3 to PE in vitro [Otomo et al. 2013],
probably due to a conformational change in ATG12–ATG5. In order to compare
ATG8s on membranes in the presence and absence of ATG16L1, as it has been done
for the yeast proteins, ATG12–ATG5 also needs to be activated without autophagic
scaffold formation. The peptide should conform to this requirement, since it lacks
the coiled-coil domain necessary for scaffold formation in yeast.
A first strategy for peptide production was co-expression of ATG16NT(1-43)
together with ATG12–ATG5 in the polycistronal expression vector pST39 (see
chapter 3.3.3). The idea was to purify the peptide directly together with ATG12–
ATG5. However, the purified peptide was degraded since its theoretical mass could
not be detected (data not shown). Also, expression as fusion protein with affinity-tags
did not yield a purified product. Otomo et al. [2013] did not use the full length
peptide, but amino acids 11-43 of ATG16L1. Thus, ATG16NT(11-43) was expressed
and purified as a fusion protein together with MBP in pCoofy4 by affinity and
size exclusion chromatography (Fig. 3.17, A). To remove MBP, the fusion protein
was subjected to PreScission protease digestion in the presence of ATG12–ATG5
at room temperature for 45 minutes and subsequently subjected to size exclusion
chromatography again for removal of MBP and protease (Fig. 3.17, B). The peak
of ATG12–ATG5-ATG16NT showed a slight shift to the left compared to ATG12–
ATG5, corresponding to an increase in hydrodynamic radius due to peptide binding
to ATG12–ATG5 ((Fig. 3.17, B, SEC profile). Mass spectrometry validated that the
peptide ATG16NT(11-43) was successfully expressed and co-purified with ATG12–
ATG5 (Fig. 3.17, C).
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Figure 3.17.: Expression, purification, and mass spectrometry of ATG16NT(11-43)
(4.4 kDa). (A) 15% SDS-PAGE gel displaying the first step for ATG16NT peptide
production: expression and purification of the fusion protein MBP-ATG16NT in E.
coli at 37°C for 3 hours; The protein was not cleaved by PreScission protease, therefore
the first elution fraction (E1) was directly subjected to SEC (corresponding profile on
the right). (B) 15% SDS-PAGE gel displaying the second step of peptide production:
PreScission protease digestion of the fusion protein from (A) in the presence of ATG12–
ATG5. The size shift of MBP (compare lane ‘bfr’ with ‘45'’) corresponds to the cleavage
process. The peptide binds to ATG12–ATG5 and can be co-purified in SEC (right
panel). The binding leads to a small shift of the ATG12–ATG5 peak (compare purple
peak for ATG12–ATG5 alone). Both SEC runs were performed on a Superdex 200
column. The peak on the right corresponds to MBP. (C) Mass spectrometry profile of
co-purified ATG16NT(11-43) with ATG12–ATG5. The detected masses are identical
with the theoretical ones, 4445 Da for ATG16NT and 47800 Da for ATG12–ATG5. The
peaks corresponding to the peptide mass display the isotopic distribution of ATG16NT.
p - pellet (insoluble fraction); sf - soluble fraction; I - input for SEC; E1, E2 - elution
fractions of Ni-batch purification; M - protein marker in kDa; A6-C10 - SEC fractions,
as indicated in the respective profile on the right.
70
Results 3.4. Conjugation of hATG8s to Giant Unilamellar Vesicles (GUVs)
3.4. Conjugation of hATG8s to Giant Unilamellar
Vesicles (GUVs)
3.4.1. ATG16L1 is necessary for hATG8 lipidation
All full-length proteins of the human ubiquitin like (UBL) systems of autophagy
were expressed and purified successfully. Thus, the UBL ‘toolbox’ was complete
and the reconstitution of the human lipidation reactions in vitro was now feasible.
Especially a characterization of potential differences of the two ATG8 families, LC3s
and GABARAPs, was in the focus of the following reconstitution experiments.
Conjugation reactions of hATG8s were established using giant unilamellar vesicles
(GUVs). GUVs are the only free-standing model membrane system that can be
investigated with fluorescence microscopy. They therefore allow for rapid accession
of lipidation efficiencies, protein visibility, as well as protein-membrane interactions
(co-localization). In the following experiments, fluorescently labeled membranes
(Phosphatidylethanolamine (PE) labeled with Atto680) were incubated with fluo-
rescently labeled proteins and their colocalization could be observed using confocal
microscopy. For the reconstitution of the lipidation reaction, two protein mixtures
were prepared: (1) ATG7, ATG3 and one of the human Atg8 homologs were pre-
incubated at 37°C with ATP for thioester intermediate formation, as well as (2)
ATG12–ATG5 with ATG16L1. Subsequently, GUVs were mixed with the two protein
compositions and after further incubation visualized by confocal microscopy.
As already indicated in an initial lipidation experiment using LUVs (chapter 3.3.5),
ATG16L1 might be necessary for a successful reconstitution of the hATG8 lipidation.
First conjugation reactions were therefore performed to compare lipidation in presence
or absence of ATG16L1. Consistent with the results on LUVs, no conjugation of
LC3B was detected with the UBL-system excluding ATG16L1 (Fig. 3.18, A and B).
Thus, ATG16L1 is necessary for conjugation of LC3B to PE in GUVs, which is in
contrast to the UBL system in yeast. When no ATG16L1 is added to the reaction
mix, LC3B is not conjugated to the membrane and it stays in the buffer surrounding
the GUVs, as well as ATG12–ATG5 (Fig. 3.18, A). In contrast, when ATG16L1
is added to the conjugation mixture, LC3B is conjugated to PE and localizes to
the membrane (Fig. 3.18, B). Therefore, colocalization of hATG8 and membrane is
equivalent to a successful conjugation, which could be verified by mass spectrometry
(L. Dempfle, master thesis). Comparable to the yeast UBL protein system, also
ATG12–ATG5 colocalizes with LC3B at the membrane. For its enzymatic activity,
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Figure 3.18.: ATG16L1 is necessary for LC3B lipidation. (A) No lipidation of LC3B
can be observed in the absence of ATG16L1. (B) Addition of ATG16L1 to the reaction
mix leads to successful lipidation of LC3B to PE (colocalizaton of membrane (red) and
LC3B (green) on surface of GUVs). (C) Fluorescent labeling of ATG12–ATG5 with
CF405M does not alter lipidation reaction. (D) The peptide ATG16NT(11-43) cannot
compensate for full-length ATG16L1. Membrane labeled with Atto680, LC3B labeled
with Alexa488, ATG12–ATG5 labeled with CF405M. Scale bar 50 µm.
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ATG12–ATG5 recognizes ATG3 in ATG3–ATG8, not ATG8 directly. Therefore, this
initial experiment indicated that ATG12–ATG5-ATG16L1 might bind LC3B actively,
since ATG12–ATG5-ATG16L1 only associated with lipidated GUV membranes.
The labeling of ATG12–ATG5 does not seem to impair lipidation efficiency, since
approximately the same number of GUVs is lipidated (compare Fig. 3.18, B with C).
Next, the enzymatic activity of the ATG12–ATG5-ATG16NT(11-43) complex
was investigated. It has been demonstrated before that ATG12–ATG5 together
with ATG16NT(11-43) was sufficient to conjugate LC3 to PE in vitro [Otomo et
al. 2013], probably due to a conformational change in ATG12–ATG5. Here, no
conjugated GUVs could be detected (Fig. 3.18, D). Also, in a lipidation experiment
with large unilamellar vesicles (LUVs) no ATG8-PE could be observed for lipidation
with ATG16NT (Fig. A.6, p. 96). These results demonstrate that, contrary to yeast
Atg12–Atg5, ATG12–ATG5 is not able to act as an E3-like enzyme alone. Rather,
the binding of ATG16L1 is likely to induce a conformational change for the efficient
conjugation of LC3B to PE. The ATG5 binding peptide ATG16NT was not able to
compensate for full-length ATG16L1 in these experiments.
3.4.2. Lipidation efficiency depends on labeling and Atg8
homolog
Knowing that ATG16L1 full-length was necessary for a successful lipidation of LC3B,
similar conditions were applied to conjugate the other human ATG8 proteins to
GUVs. The lipidation reaction could be stably reproduced for all four hATG8s
(Fig. 3.19). To investigate the influence of protein labeling on conjugation efficiency,
several labeling conditions were tested. Because labeling of ATG16L1 with Atto590
impaired lipidation efficiency (Fig. A.7), Alexa488 was used for labeling of ATG16L1.
Strikingly, a reproducible difference in lipidation efficiency for ATG8s was observed.
This characteristic was exhibited in all experiments (Fig. 3.19). A quantification of
lipidated GUVs yielded the result that LC3A and GATE-16 were not as efficiently
conjugated compared to LC3B and GABARAP, with GABARAP being the ATG8
protein that shows the highest lipidation efficiency (Fig. 3.20). Activity of ATG16L1
was variable, resulting in an almost saturated lipidation efficiency in some experiments
(Exp3, Fig. 3.20).
In summary, the reconstitution of the human autophagic UBL machinery yielded
new results regarding possible diverging functions of hATG8s in autophagosome
formation. Lipidation efficiency varied strongly between Atg8 homologs, independent
of their subfamily. Interestingly, even in case of apparent optimal lipidation conditions,
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Figure 3.19.: The lipidation reaction with hATG8s labeled with Atto590 and
ATG16L1 with Alexa488. HATG8s show different conjugation efficiencies, depen-
dent on the protein used. (A) LC3A, (B) LC3B, (C) GABARAP, (D) GATE-16.
Scale bar 50 µm.
74
Results 3.5. FRAP experiments on GUVs
lipidation efficiency of GATE-16 remained below 40 %, indicating a deviant function
of GATE-16 compared to the other hATG8s.
Figure 3.20.: Quantification of lipidated GUVs for three different experiments, n>100
GUVs counted for each experiment.
3.5. FRAP experiments on GUVs
The observation, that ATG12–ATG5-ATG16L1 is retained only on membranes
conjugated with ATG8 suggests that a scaffold, similar to the one in yeast, is formed.
First evidence of the autophagic membrane scaffold in yeast came from fluorescence
recovery after photobleaching (FRAP) experiments. In FRAP experiments, part
of the sample is bleached with very strong laser power and the recovery of the
fluorescence is monitored. This experiment sheds light on the mobility of the labeled
components in the sample. If fluorescence does not recover at all or only to a
very limited extend, the majority of fluorescently labeled components is immobile.
Such results indicate that the labeled components form large scale macromolecular
assemblies, which diffuse slowly. Therefore, these experiments are well suited as first
indications, whether a scaffold is being formed with the human UBL system.
FRAP experiments were conducted on GUVs which were successfully lipidated with
hATG8 proteins. Part of the GUV was bleached and recovery was monitored for the
labeled components in the reaction: the membrane, the ATG8 protein, and ATG16L1.
To compare mobility of different Atg8 homologs, similar experimental conditions were
applied (Fig. 3.22). Strikingly, the immobile fraction of ATG16L1 is close to 100 %
in all four ATG8 homologs tested. Similarly, the immobile fraction of the human
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Figure 3.21.: Quantified immobile fraction of the labeled components in the exper-
iment, membrane, ATG16L1, and corresponding ATG8 protein; n=3 independent
experiments, at least 4 GUVs each.
ATG8 homologs is very high, close to 80 %. Membrane lipids, however, display
unlimited diffusion and most of the fluorescence signal recovered, corresponding
to an immobile fraction of 30-40 % (Fig. 3.21). This unexpected immobile fraction
of the lipids is due to experimental conditions. Extensive irradiation, that was
required for efficient bleaching, lowered fluorescence in non-bleached areas as well,
since lipids diffuse rapidly in the membrane. Therefore the GUV as a whole became
bleached and could not recover full fluorescence (e. g. Fig. 3.22, A). Additionally, the
imaging process after the bleaching event is too slow to catch the bleached area
in the membrane directly after the bleaching, again due to rapid lipid diffusion.
Therefore, membrane fluorescence is already recovered partially in the bleached area
(e. g. Fig. 3.22, D). Both facts contribute to a systematic error in the calculation of
the immobile membrane fraction.
Nevertheless, the remarkable effect was the little recovery of ATG16L1 and the
human ATG8 proteins. These results hint very strongly to the assumption that
indeed also human UBL proteins are part of an autophagosomal membrane scaffold.
Noteworthy, all ATG8 proteins tested, namely LC3A, LC3B, GABARAP, and
GATE-16, demonstrate comparable immobility of ~80 % (Fig. 3.21). These findings
give rise to the idea that in vitro, all hATG8s have the potential to form a protein
scaffold.
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Figure 3.22.: Individual FRAP experiments on lipidated GUVs with ATG8s. Ar-
rowheads point to bleached area. On the right the corresponding relative fluorescence
intensity of the experiment is displayed. Fluorescence was set to 100 % for all channels
before bleach. The strong decline corresponds to the bleaching timepoint and fluo-
rescence recovery was monitored for at least 5 minutes. (A) LC3A, (B) LC3B, (C)
GABARAP, (D) GATE-16. Scale bar 5 µm.
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Discussion
4.1. The autophagic scaffold in yeast
Despite the important role for autophagy in development, ageing, and a wide range
of diseases such as cancer, neurodegeneration, or infections, mechanistic insights into
the formation of autophagosomes are still limited. The interplay of Atg proteins and
protein complexes, which orchestrate the formation of this double membrane structure
is up to now a matter of debate. Regarding the maturation of the phagophore, it is
still unknown how membrane extension is regulated and which mechanism defines
the size of autophagosomes. In specific autophagy, cargo determines the size, because
the autophagosomal membrane wraps tightly around the cargo, e. g. damaged
mitochondria [Xu et al. 2015]. For unspecific autophagy, typical autophagosomal
diameters range from 300 to 900 nm in yeast and 0.5 to 1.5 µm in mammalian cells
[Shibutani et al. 2014]. But how is this size controlled? Interestingly, the amount of
Atg8, an Ubiquitin like protein conjugated to Phosphatidylethanolamine (PE) on the
autophagosomal membrane, determines the size of autophagosomes [Xie et al. 2008a].
The conjugation of Atg8, also referred to its ‘lipidation’, is catalyzed by the protein
complex Atg12–Atg5-Atg16, with Atg12 being the second Ubiquitin-like protein
in autophagy. In vitro, Atg12–Atg5 is sufficient to conjugate Atg8 to membranes
[Hanada et al. 2007]. In vivo, however, Atg12–Atg5 always associates with Atg16
and remains associated with the phagophore [Kuma et al. 2002; Suzuki et al. 2007].
These findings raised further questions: First, why is Atg12–Atg5 retained on the
autophagosomal membrane during the expansion of the phagophore, when its sole
function is the conjugation of Atg8 to Phosphatidylethanolamine (PE)? Also, the
fact that Atg16 binds to Atg12–Atg5 when it is not necessary for the enzymatic
reaction in vitro was obscure, especially with regard to the somewhat extraordinary
elongated structure of Atg16, and its dimer formation. And secondly, what is the
purpose of Atg8 decorating the outer membrane of the phagophore, which constitutes
the main characteristic of phagophores and autophagosomes? It is well established
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that Atg8 acts as cargo adapter on the inner membrane, yet the function of Atg8
binding to the outer membrane remained unexplained.
Previous work in the lab has revealed, that Atg8 is immobilized on liposomes by
Atg12–Atg5-Atg16, but not by Atg12–Atg5. These findings confirmed the enzymatic
activity for Atg12–Atg5, but implicated a structural function for Atg16. Based on
these experiments, the hypothesis was developed, that Atg8 together with Atg12–
Atg5-Atg16 is forming a so far undescribed protein scaffold on the phagophore
membrane. To verify this hypothesis and unravel the structural organization of the
scaffold on the membrane, high-resolution imaging was essential. However, electron
microscopy on liposomes would have been technically very challenging, because giant
unilamellar vesciles (GUVs) are unstable and previous experiments showed that
large unilamellar vesicles are too small for scaffold formation. Therefore, Atomic
Force Microscopy (AFM) was the method of choice to confirm and investigate the
hypothesized autophagic scaffold.
For imaging the autophagic scaffold with AFM, the lipidation reaction had to
be reconstituted on supported lipid bilayers (SLBs). After optimizing the support
and adjusting protein concentrations, Atg8 was successfully conjugated to PE on
SLBs. Interestingly, regular sized particles with a diameter of 50 ± 10 nm could
be observed, consisting of Atg8 and Atg12–Atg5 (Fig. 3.4). Atg8 has an estimated
diameter of 3 nm (PDB no. 3VXW) and Atg12–Atg5 dimensions of 6 nm x 4 nm
(PDB no. 3W1S). Therefore, these particles were too large for single Atg8 molecules
or one Atg8–PE/Atg12–Atg5 complex. Taking into account that the horizontal
resolution of the AFM is limited by the width of the cantilever and the lateral
mobility of the particles, these complexes consisted of at least two, but not more
than four Atg8–PE/Atg12–Atg5. Previous studies showed that Atg8 has the ability
to multimerize in response to conjugation with PE [Nakatogawa et al. 2007]. Hence
it can be concluded, that Atg8 is at the core of these complexes, forming dimers,
trimers, or tetramers, and Atg12–Atg5 is binding to Atg8, thereby extending the
dimension of the complexes.
When Atg16 was added to the reaction mixture, the appearance of the proteins
changed drastically. A flat protein layer could be observed, which exhibited a
meshwork-like architecture (Fig. 3.3). The crystal structure of Atg16 revealed a
stretch of exposed hydrophobic residues in Atg16, which stabilized a crystal contact
between two antiparallel Atg16 dimers [Fujioka et al. 2010]. This finding indicated,
that Atg16 forms antiparallel tetramers, which was supported by the observation
that the edge length of the meshwork was 17 ± 4 nm, comparable to the length of an
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Atg16 tetramer (Fig 3.6). Taken together, these findings are in agreement with the
hypothesis, that indeed the autophagic UBL systems, Atg8 and Atg12–Atg5-Atg16,
assemble into a protein scaffold in vitro. The scaffold consists of two building blocks,
Atg8–PE/Atg12–Atg5 complexes and Atg16 antiparallel tetramers, which link Atg8–
PE/Atg12–Atg5 complexes and therefore organize them into a continuous protein
layer that is linked to the membrane via Atg8–PE (Fig. 4.1).
Figure 4.1.: Cartoon representing the possible mode of interaction of yeast autophagic
UBL proteins involved in autophagic scaffold formation. (Left) Atg8 interacts with
itself and therefore clusters Atg8–PE/Atg12–Atg5 complexes in oligomers, consisting
of two to four subunits (here interaction of two subunits is drawn). Atg16 cross-links
these oligomers via antiparallel coiled-coil formation. (Right) The autophagic scaffold
forms on the convex side of the phagophore, whereas Atg8 serves as cargo adaptor
molecule on the concave side.
4.1.1. The autophagic scaffold in comparison to canonical
membrane coats
AFM revealed intriguing similarities of the autophagic membrane scaffold in com-
parison to canonical membrane coats (clathrin, COPI, and COPII). The 8 nm thick
autophagic scaffold resembles the height of COPII (10nm), clathrin (12nm), and
COPI (14nm, Faini et al. [2012]) protein layers. Furthermore, the edges of the
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autophagic membrane scaffold are built by antiparallel coiled-coil domains of Atg16.
These rod-shaped building blocks are comparable to to the rod-shaped coat com-
ponents of canonical coats, which form cage-like structures. Strikingly, even the
dimensions of these lattices are comparable. The edge-length of 17 nm measured
by AFM for the autophagic membrane scaffold lies in the same range as the edge
length of other membrane coats: 18 nm in clathrin coats [Kirchhausen et al. 1984],
13 nm in COPII and 14 nm in COPI [Faini et al. 2013]. Therefore, with respect to
building block dimensions, the autophagic scaffold appears structurally analogous to
canonical membrane coats.
The meshwork-like architecture of the autophagic membrane scaffold, unveiled
by AFM, proved to be flexible, since it could form from nano- to macroscopic scale
on flat membranes and round liposomes (Fig. 3.4). Therefore the scaffold meets
its biological requirements, since it exhibits flexibility in size and shape, which is
required for forming autophagosomes ranging from 300 to 900 nm [Shibutani et al.
2014].
Interestingly, AFM demonstrated, that the structure of the autophagic scaffold
exhibits a lower degree of structural organization, compared to clathrin and COPII.
Similarly, also COPI coated vesicles display a high amount of structural flexibility
[Faini et al. 2013], since cargo of different sizes is transported and the structure
of the COPI coat varies in response to membrane curvature [Beck et al. 2008]. In
COPI, the structural flexibility is realized via its triangularly shaped repeated unit,
which can interact in four different patterns [Faini et al. 2013]. However, transport
vesicles enclosed by COPI range in size from 50 to 100 nm and are therefore one
magnitude smaller than autophagosomes. Structural flexibility of the building blocks
allows therefore assembly of COPI coats on vesicles with different sizes, shapes and
curvature, providing diverse cargo to be sequestered and transported [Faini et al.
2013]. With respect to the autophagic scaffold, particle analysis revealed that Atg8–
PE/Atg12–Atg5 complexes are homogeneous in size (Fig. 3.4). This finding indicated
that only one type of oligomer, either two, three, or four Atg8–PE/Atg12–Atg5
complexes, are assembled into the scaffold. Since autophagosomes are one magnitude
larger compared to other transport vesicles, it is not necessary to change the geometry
of building block assembly to meet a broad size range. Rather, flexibility is provided
by conformational freedom of the building blocks relative to each other and the
scaffold can be viewed as a supporting meshwork for phagophores.
The observed lower structural organization could be derived from the unregulated
way of assembly, since in vitro, Atg8 is conjugated at several sites on SLBs, and
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assembly is driven by diffusion, with no active force involved. Since it was shown
before that the autophagic proteins act in a hierarchical manner [Suzuki et al. 2007],
it can be assumed that in vivo, scaffold assembly is regulated by upstream factors,
allowing for a more homogeneous structural organization.
Despite its structural similarities, a difference to canonical coats is the spatial and
functional separation between scaffold formation on the convex side of the phagophore
and cargo-binding via Atg8–PE on the concave side of the phagophore (Fig. 4.1,
right). Both tasks are spatiotemporally coordinated in canonical membrane coats,
due to direct interactions of cargo-adapters and coat components via transmembrane
domains of participating proteins. This spatiotemporal coordination is not possible
due to the double-membrane nature of the autophagosome and Atg8 attached to
the both convex and concave face. Additional experiments in the lab revealed, that
cargo receptor molecules compete for Atg8–PE binding with Atg12–Atg5-Atg16
and are able to disrupt the scaffold. This competitive binding to Atg8 might allow
tethering of cargo to the inner membrane for engulfment. Additionally, it remains
to be investigated whether the scaffold forms in specific autophagy, since in specific
autophagy, the form of the autophagsome is defined and an additional structural
support for the membrane might not be necessary.
In addition to its similarities and differences to canonical membrane coats, the
autophagic membrane scaffold exhibits some unique features. It is so far the only
described membrane scaffold that is covalently linked to lipids. For other canonical
coats transmembrane domains of participating proteins provide the connection to
the membrane.
Furthermore, it is the only scaffold in which an enzyme catalyzes a primary reaction
for coat formation and in a second step participates in coat formation. For the
autophagic scaffold, Atg12–Atg5-Atg16 first catalyzes the conjugation reaction of
Atg8 to PE and is then in a second step integrated into the scaffold by interacting
with conjugated Atg8.
Finally, COPII and clathrin are able to self-associate without cargo or membrane
into regular sphere-like structures [Stagg et al. 2006; Fotin et al. 2004]. This is not
the case for the autophagic scaffold. Atg8 is only able to multimerize when it is
conjugated to PE [Nakatogawa et al. 2007], indicating a conformational change upon
conjugation [Ichimura et al. 2004]. In line with this finding, a conformational change
of an ‘open’ and ‘closed’ conformation could be demonstrated for GABARAP, a
human homolog of Atg8 [Coyle et al. 2002]. Therefore, the conjugation reaction is a
prerequisite for scaffold formation, and the autophagic scaffold can only form with
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lipidated Atg8 in ‘open’ conformation.
In summary, the building blocks of the autophagic membrane scaffold exhibit
similar dimensions compared to the building blocks of canonical vesicle coats. The
flexibility of the scaffold meets biological requirements since it can form on liposomes
and flat membranes from micro- to nanoscopic scale. The observed organizational
irregularity could be a related to the experimental in vitro system, since particle
analysis revealed homogeneous building blocks. Furthermore, upstream factors
regulate assembly in vivo, but were not included in the reconstitution. The covalent
linkage to lipids, the dual function of Atg12–Atg5-Atg16 as conjugating enzyme
and coat component, as well as spatial separation of scaffold formation and cargo
selection constitute unique characteristics of the autophagic membrane scaffold.
4.1.2. Previous discussions about a possible
autophagosomal membrane scaffold
Interestingly, it has been suggested before that Atg12–Atg5-Atg16 might be involved
in the formation of a coat on autophagosomes, due to its oligomerization and its
localization to the elongating phagophore. Yet, direct evidence was missing [Kuma
et al. 2002]. Conversely, a quantitative study on yeast Atg proteins came to the
conclusion, that the number of Atg16 proteins on the phagophore is not enough to
cover it completely and therefore scaffold formation is unlikely [Geng et al. 2008]. In
the latter study, Atg proteins were tagged with fluorescent proteins. The estimated
number of Atg8 molecules at the phagophore was determined to be a magnitude
higher compared to Atg16 amounts and the authors stated that Atg5- or Atg12-tagged
proteins were hardly detectable. Since fluorescent fusion proteins presumably hinder
interaction and therefore coat formation, protein numbers of Atg12–Atg5-Atg16 were
most likely underestimated. Additionally, the diverging number between Atg16 and
Atg8 could be explained if the scaffold would not form on the complete curvature
of the phagophore, but only partly to stabilize the growing membrane structure.
Experimental evidence suggests that this might be true for phagophores in plants,
where ATG5 defines a ring-like domain on the expanding phagophore [Le Bars et al.
2014].
Finally, the maintenance of curvature and structural stabilization of the entire
phagophore represents an energetic challenge. This is especially the case for bulk au-
tophagy, where no substrate, e.g. a damaged mitochondrion, stabilizes the membrane
structure [Hurley et al. 2014]. Hence, the autophagic membrane scaffold described
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here might serve to stabilize the phagophore membrane. This assumption is in line
with previous experiments in the lab, which demonstrated that lipidated GUVs were
able to withstand larger osmotic pressure compared to uncoated GUVs.
4.2. Varying roles for Atg18 and Atg21 in
autophagosome formation
The finding of a so far undescribed membrane scaffold on the phagophore raises
the question, how scaffold formation is triggered at the beginning of phagophore
expansion. The answer to this question could lie in the proteins acting upstream
of the Atg8 conjugation machinery. Two candidates, which could be involved in
recruiting Atg12–Atg5-Atg16 to the phagophore, are Atg18, forming a complex with
Atg2 [Suzuki et al. 2007], and Atg21. It could be verified recently, that indeed Atg21
is able to recruit Atg12–Atg5-Atg16 to the autophagosomal membrane through
direct interaction with Atg16 [Juris et al. 2015]. Furthermore, WIPI2b (WD-repreat
PtdIns(3)P effector protein 2b), the mammalian homolog of Atg18, directly binds
ATG16L1 and therefore recruits ATG12–ATG5-ATG16L1 to the autophagosomal
membrane [Dooley et al. 2014]. However, upon knockout of Atg18 or Atg2, the
localization of Atg12–Atg5-Atg16 or Atg8 was not affected, hinting either towards
another role of the Atg2-Atg18 complex during autophagosome formation or to a
compensatory effect of Atg21 [Suzuki et al. 2007].
To decipher the individual roles of Atg18 and Atg21, transmission electron mi-
croscopy (TEM) was performed on knock out strains of these two proteins. Addi-
tionally, cells were deficient for the vacuolar protease Pep4, leaving vacuolar cargo
undegraded. TEM imaging revealed, that smaller and fewer autophagic bodies are
forming in ΔAtg21 cells. This result is in line with the finding that Atg21 recruits
Atg12–Atg5-Atg16 to the phagophore [Juris et al. 2015]. Upon knock out of Atg21,
Atg12–Atg5-Atg16 cannot be recruited to the autophagic membrane as efficiently
any more. Therefore, Atg8 is lipidated to a lesser extend to the growing phagophore,
which corresponds to smaller autophagosomes [Xie et al. 2008a]. Conversely, no
autophagic bodies could be detected in Atg18 knock out cells. Furthermore, it was
not possible to rescue this phenotype by an overexpression of Atg21, leading to
following conclusions: Atg18 function diverges from Atg21 function due to its distinct
phenotype upon knock out. Additionally, since Atg21 cannot compensate for the loss
of Atg18, a functional redundancy during starvation can be excluded. Interestingly,
fine-mapping of Atg proteins revealed that Atg18 localizes to the edge of the growing
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phagophore [Suzuki et al. 2013], indicating a role in autophagosomal closure. In
summary, despite the similarity of Atg18 to Atg21 or WIPI2, Atg18 could play a
role during phagophore closure and not necessarily in recruiting Atg12–Atg5-Atg16.
4.3. The autophagic scaffold in humans
Yeast has been the model organism for many ground-breaking discoveries in autophagy.
Because Atg proteins are well conserved across species and phyla, findings in yeast
often apply to mammals as well. Therefore, the discovery of an undescribed membrane
scaffold on phagophores directly implied the question, whether such a scaffold is
forming with the homologous proteins in humans. Such a verification would add
important information to the understanding of autophagy in humans. Furthermore,
underlying protein-protein interactions could be new targets for treating autophagy
related diseases.
For the confirmation that a similar scaffold exists in humans, both human au-
tophagic UBL systems had to be reconstituted in vitro. In this thesis, this complete
reconstitution was achieved in its entirety for the first time. The purification of the
human UBL components was more difficult compared to the yeast UBL systems.
First, different isoforms of the proteins exist, which complicated the search for the
right protein combinations, especially in the case of ATG7. Second, the human
proteins possess a more complex architecture, e. g. the WD-domain of Atg16L1,
whose folding is enhanced by eucaryotic chaperones [Miyata et al. 2014]. Therefore,
earlier studies never contained the entire set of proteins that are involved in the two
conjugation reactions of hATG8s and ATG12. Especially full-length ATG16L1, an
indispensable part of the yeast autophagic scaffold, has not been purified before.
Moreover, with the ‘toolbox’ of the human autophagic UBL proteins in hand, it
was now feasible to shed some light on potential differences between ATG8 proteins.
Here, yeast cannot provide an answer, since Atg8 follows the premise ‘one for all’,
meaning Atg8 alone fulfills all tasks that might be split in higher eucaryotes, due to
the division of ATG8 proteins in its subfamilies LC3s and GABARAPs.
In this thesis, two major findings were made with the reconstituted human UBL
systems: (1) A difference in lipidation efficiency between ATG8s could be observed.
ATG8s tested were LC3A and LC3B, belonging to the LC3 family, and GABARAP
and GATE-16, representing the GABARAP family. Unexpectedly greater differences
were detected within subfamilies, with GABARAP showing the highest lipidation
efficiency to GUVs, followed by LC3B. LC3A and GATE-16 showed very low lipidation
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efficiency. (2) In vitro FRAP (fluorescence recovery after photobleaching) experiments
strongly implied the formation of a human autophagic membrane scaffold, notably
with all ATG8s purified here.
4.3.1. Reconstituted lipidation reaction with hATG8s
It was unclear, whether the human system behaves similarly in GUV experiments
compared to the yeast system. Specifically, contradictory results have been published
regarding the requirement of ATG16L1 in in vitro lipidation experiments. On the
one hand, successful lipidation of LC3 to PE has been achieved on LUVs with the
ATG5 binding region of ATG16L1, ATG16NT(11-43) [Otomo et al. 2013]. On the
other hand, a high DOPE content was sufficient for a successful lipidation without
presence of neither ATG12–ATG5 nor ATG16L1 [Nath et al. 2014].
Observations in this thesis on GUVs demonstrated that ATG12–ATG5-ATG16L1
is required for lipidation of hATG8s (Fig. 3.18, L. Dempfle master thesis). The
ATG5 binding region of ATG16L1 (ATG16NT11-43) was, however, not sufficient for
lipidation of hATG8s to GUVs. This finding is in contrast to the yeast system, where
Atg12–Atg5 was sufficient for Atg8 lipidation. Interestingly, no LC3 is conjugated to
autophagosomal membranes upon deletion of only the coiled-coil domain of ATG16L1
in vivo [Saitoh et al. 2008]. This confirms the finding from this thesis, that ATG16L1
is needed for the lipidation of hATG8s in vitro. Presumably, ATG16L1 causes a
conformational change in ATG12–ATG5, which activates the enzymatic activity of
ATG12–ATG5. This finding also implies that the coiled-coil region, and thus dimer
formation, is required for the lipidation of hATG8s. The observation, that lipidation
can be achieved in vitro by ATG16NT on small vesicles with high DOPE-content
Otomo et al. [2013] suggests, that highly stressed and instable membranes counteract
the requirement of ATG16L1. However, such systems do not represent the situation
in vivo, where phagophores are flat membrane sacs with PE-contents below 20-30 %.
The main question to be answered with the in vitro reconstituted lipidation
reaction was, if hATG8s have distinct roles during autophagosome formation, and
if they therefore behave differently in GUV experiments. Surprisingly, hATG8s
demonstrated varying lipidation efficiencies, with biggest discrepancies within hATG8
families. LC3A and GATE-16 showed a similar low efficiency compared to LC3B
and GABARAP with a high lipidation efficiency.
The study by Weidberg et al. [2010] implied that LC3s act before GABARAPs
in autophagosome formation. There, knockdowns of hATG8s in HeLa cells were
performed targeting whole subfamilies. These knockdowns were rescued by over-
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expression of either LC3B or GATE-16. Based on these experiments, the authors
drew conclusions for the whole subfamily, so for LC3s and GABARAPs, respectively.
In line with the results published by Weidberg et al. [2010], experiments in this
thesis revealed different lipidation efficiencies for LC3B and GATE-16. Lipidation
efficiency of LC3B was relatively high, whereas GATE-16 showed the lowest lipidation
efficiency in all experiments. Assuming that a high lipidation efficiency is necessary
for phagophore expansion, it is possible that LC3B acts during phagophore growth
and GATE-16 acts at later stages of autophagosome formation, possibly closure.
However, and this is in contrast to the conclusions drawn by Weidberg et al. [2010],
GABARAP demonstrated the highest lipidation efficiency in GUV experiments.
Hence, not GABARAPs as a whole subfamily but possibly GATE-16 alone acts
at later stages of autophagosome formation. Similarly, the lipidation efficiency of
LC3A lied in the same range as GATE-16. Therefore, assuming that LC3s as a
whole subfamily are necessary for phagophore expansion and GABARAPs for later
stages of autophagosome formation might not be true in vivo. Assuming again that
a high lipidation efficiency is needed for phagophore growth, GABARAP could act
before GATE-16. Interestingly, this assumption would support the study by Szalai
et al. [2015], where the authors find LC3s completely dispensable for autophagosome
formation in rat hepatocytes, implying that GABARAP can compensate at least
partially for loss of LC3B.
In conclusion, the growth of the phagophore could be dependent on hATG8s with
high lipidation efficiencies, namely LC3B or GABARAP, and GATE-16 could act
at a later stage of autophagosome formation. Which of the proteins is responsible
for phagophore growth might be susceptible to cell type. Nevertheless, functional
redundancy of hATG8s to a certain extent during autophagosome expansion should be
considered as well. All hATG8s reveal a variety of non-identical binding partners and
different cargo-specificities. Therefore, not every hATG8 protein comes necessarily
with a different role in autophagosome maturation.
4.3.2. Possible scaffold formation with human UBL
autophagic proteins
The homology of the UBL protein systems between yeast and mammals implied,
that a comparable autophagic membrane scaffold could form in mammals, as was
observed with yeast proteins. In vitro FRAP experiments revealed, that the human
UBL proteins show comparable immobile behavior on GUVs to the yeast proteins,
implying scaffold formation. Moreover, similar immobile behavior was observed for all
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hATG8s tested, namely LC3A, LC3B, GABARAP and GATE-16. Although diverging
lipidation efficiencies were observed for hATG8s, all hATG8s on lipidated GUVs
showed similar immobility. Likewise, ATG16L1 appeared to be almost completely
immobile on all GUVs tested, unrelated of the hATG8 used. These results imply
that in vitro, possibly both LC3s and GABARAPs possess the ability to form a
scaffold-like structure on membranes.
Human ATG16L1 also possesses, like Atg16, an ATG5 binding domain and a
coiled-coil region for dimer formation. The assumption for the human scaffold was
that, according to Atg16, dimers form antiparallel tetramers through interactions
within the coiled-coil domain of ATG16L1. Interestingly another homolog of Atg16,
ATG16L2, was recently described, which is not involved in autophagy albeit forming
an ATG12–ATG5-ATG16L2 complex with dimer formation of ATG16L2 [Ishibashi
et al. 2011]. ATG16L2 shows high sequence homology to ATG16L1 in its N-terminal
(ATG5 binding) and WD-repeat region, but only little homology (20,7% amino acid
identity) in its coiled-coil region. The authors assume that this functional discrepancy
might stem from a key factor, possibly Rab33B, that can bind to ATG16L1 but
only very weakly to ATG16L2, and therefore induces autophagy. However, assuming
that ATG12–ATG5-ATG16L1 assembles the same way as Atg12–Atg5-Atg16, it
is plausible that ATG16L2 is not able to form the tetramer needed for scaffold
formation due to its non-homologous coiled-coil region.
The binding of Rab33B GTPase to the coiled-coil domain of ATG16L1 has been
reported before [Itoh et al. 2008]. Rab33B binding possibly modulates autophagy
by regulating the availability of ATG16L1 in the cytoplasm. Fukuda et al. [2008]
suggest that upon induction of autophagy, another protein X binds to the coiled-coil
domain of ATG16L1. This Protein X could likely be ATG16L1 itself, forming a
tetramer during phagophore growth, as part of the autophagic membrane scaffold. In
summary, it was shown before that the coiled-coil domain of ATG16L1 is important
for autophagosome formation, however the reasons were not completely understood.
Results from this thesis indicate that, comparable to yeast Atg16, ATG16L1 dimers
form antiparallel tetramers in the coiled-coil region, which leads to similar immobility
of the autophagic UBL proteins on GUVs as was the case for yeast in in vitro
experiments.
The second building block besides Atg16 tetramers in the yeast autophagic mem-
brane scaffold are Atg8–PE/Atg12–Atg5 complexes, where Atg8 oligomerizes with
itself. Atg8 undergoes a conformational change upon binding to PE [Ichimura et
al. 2004]. This ‘open’ conformation of Atg8-PE induces oligomerization of Atg8–
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PE/Atg12–Atg5. Similarly, an ‘open’ and ‘closed’ conformation was described for
GABARAP and it was proposed that GABARAP can self interact in open confor-
mation [Coyle et al. 2002]. However, no experimental evidence was found for this
interaction so far. Yet, NMR spectroscopy confirmed that GABARAP is able to
adopt at least two conformations [Weiergräber et al. 2013]. Assuming a similar mode
of self-interaction between hATG8s as compared to Atg8, immobility of the human
UBL proteins in FRAP experiments implies self-interaction for all hATG8s. It needs
to be elucidated if this self-interaction depends in all cases on a conformational
change.
In summary, FRAP experiments demonstrated immobility of hATG8s and ATG12–
ATG5-ATG16L1 on GUVs in vitro, comparable to similar experiments with yeast
autophagic proteins. Remarkably, all hATG8 proteins displayed akin immobility.
Further experiments are needed to confirm, if the observed immobility indeed involves
scaffold formation. In case this hypothesis holds true, a new perspective might arise
on autophagosome formation in humans.
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The finding that Atg8 and Atg12–Atg5-Atg16 are part of a new membrane scaffold
could answer many questions in the autophagy field regarding these proteins. Never-
theless, the AFM studies presented here can only be a start for further investigations
of the autophagic membrane scaffold. Particularly its structural organization should
be of future interest. With high resolution techniques, such as Cryo-electron mi-
croscopy, it could be analyzed in more detail if Atg8–PE/Atg12–Atg5 complexes
consist of two, three, or four Atg8–PE/Atg12–Atg5 particles. Other promising
approaches could be electron microscopy after chemical fixation of the scaffold
on supported lipid bilayers with glutaraldehyde, or super resolution fluorescence
microscopy methods, such as PALM (photoactivated localization microscopy) or
STORM (stochastic optical reconstruction microscopy).
Also, it remains elusive whether the autophagic scaffold forms on the complete
growing phagophore or if it only stabilizes parts of the phagophore. Stabilization of
the phagophore rim seems to be the case in plant autophagy, where ATG5 could be
detected at the rim of growing phagophores by three-dimesional TIRF (total internal
reflection fluorescence) microscopy [Le Bars et al. 2014]. However, fine-mapping
of Atg proteins in yeast on giant cargo revealed an even distribution of Atg16 on
the phagophore [Suzuki et al. 2013]. Nevertheless, a similar approach should yield
new information on the in vivo formation of the autophagic membrane scaffold,
specifically with respect to regulated recruitment of the scaffold building blocks.
Here, nucleation experiments with upstream factors, e. g. Atg21, could provide a
new view on autophagic scaffold assembly, by recruiting these factors to the plasma
membrane followed by TIRF imaging. A similar approach in vitro with ultra-fast
AFM on supported lipid bilayers could complement these experiments.
With respect to the human autophagic scaffold, a direct proof is needed for
verification of scaffold formation, comparable to AFM studies. It will be interesting
to observe, if the scaffold shows a similar structural organization compared to
yeast. Also, possible structural differences between hATG8 proteins should be
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investigated. Using mixtures of hATG8s on GUVs for FRAP experiments and
lipidation efficiencies should yield further insights into possible separate roles of
ATG8s during autophagsosome formation. E. g. ATG8s possibly show diverging
mobility in FRAP experiments when used in mixtures, hinting towards a different
integration ability into the scaffold.
In vitro time-lapse experiments using the yeast UBL proteins revealed an hierarchi-
cal binding of Atg12–Atg5. In a first step Atg12–Atg5 binds Atg3–Atg8 and thereby
catalyzes the binding of Atg8 to the membrane. In a second step, Atg12–Atg5 is
recruited to the membrane by conjugated Atg8 via a noncanonical Atg8 interact-
ing motif in Atg12. Time-lapse experiments of human UBL proteins could reveal
if protein interactions follow a similar sequence compared to yeast UBL proteins.
Additional GUV experiments should comprise binding assays with ATG4 and cargo
adaptors to examine if the scaffold can be resolved by competitive binding.
Last but not least the in vitro results obtained so far should be complemented
by in vivo autophagy assays using living cells. Especially knock-down experiments
of single ATG8s, e. g. only GABARAP or GATE-16, should demonstrate, if the
hypothesized functions of single ATG8s can be verified in vivo. Furthermore, super
resolution fluorescence microscopy could reveal whether ATG8 proteins demonstrate
distinct localization and function during phagophore expansion.
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A.1. ATG12–ATG5 production attempts
Figure A.1.: Attempts to express proteins for the production of ATG12–ATG5. (A)
12 % SDS-PAGE gel of NusA-ATG12 purification steps expressed in E. coli BL21.
Left from the protein marker different steps of affinity chromatography are displayed,
on the right fractions from size exclusion chromatography (SEC). Even though the
fusion protein was not cleaved before subjection to SEC, degradation can be detected
(compare band of NusA at 59 kDa to band of fusion protein at 74 kDa).
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(Continued from previous page) (B) 12 % SDS-PAGE gel of ATG7 (isoform 1) purifi-
cation steps expressed in E. coli BL21, with additional chaperone expression (vector
pG-KJE8, Takara). Left from the protein marker different steps of affinity chromatog-
raphy are displayed, on the right fractions from SEC. ATG7 (78 kDa) could not be
detected in mass spectrometry, instead all proteins purified during SEC corresponded
to chaperones. (C) Test expression samples on 12 % SDS-PAGE gel of different poly-
cistronic vectors for Atg12–Atg5 production, expressed in E. coli Tuner pLac. The
vectors contained cDNA for ATG7 (isoform 2), ATG10, ATG12, ATG5, and ATG16 or
TECPR, as indicated. No band corresponding to the Atg12–Atg5 conjugate can be
detected in the pull down (47 kDa), instead the band at 30 kDa most probably corre-
sponds to ATG5. ni - not induced sample; ind - induced sample; p - pellet (insoluble
fraction); sf - soluble fraction; E1, E2 - elution fractions of Ni-batch purification; I -
input (for SEC); M - protein marker in kDa; A5-C8 - SEC fractions.
A.2. Testexpression of ATG7 in insect cells
Figure A.2.: Immunoblot of ATG7 test expression results with Anti-ATG7 antibody,
samples provided by the Biochemistry Core Facility. ATG7 was cloned into three
vectors containing different affinity tags, suitable for insect cell expression: pCoofy27
(His-tag), pCoofy28 (GST-tag), and pCoofy29 (MBP-tag). SF9 and H5 represent
different insect cell lines for recombinant protein expression. Ascending numbers
indicate used BIIC dilutions: 1:500, 1:1000, 1:2000, 1:4000 (1-4, 5-8,. . . ). Here, best
results were obtained in SF9 cells, either from pCoofy27 (lane8) or from pCoofy28
(lane16).
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Figure A.3.: 10% SDS-PAGE gel of ATG7 medium scale test expression and pull-
down from samples 8 and 16 in figure A.2. Protein amount was higher from pCoofy27
expression compared to pCoofy28 (large protein band between 70 and 80 kDa).
A.3. Testexpression of ATG16L1 in insect cells
Figure A.4.: Immunoblot of ATG16 test expression results with Anti-His antibody,
samples provided by the Biochemistry Core Facility. ATG16 was cloned into three
vectors containing different affinity tags, suitable for insect cell expression: pCoofy27
(His-tag), pCoofy28 (GST-tag), and pCoofy29 (MBP-tag). SF9 and H5 insect cell
lines were tested. Ascending numbers indicate used BIIC dilutions: 1:1000, 1:2000,
1:4000. Here, best results were obtained in H5 cells, either from pCoofy27 (lane1) or
from pCoofy29 (lane13).
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Figure A.5.: 10% SDS-PAGE gel of ATG16 medium scale test expression and pull-
down from samples 1 and 13 in figure A.4. More protein was obtained from pCoofy29
expression compared to pCoofy27 (arrow heads).
A.4. Additional lipidation experiments
Figure A.6.: Lipidation reaction with large unilamellar vesicles (LUVs). The
lower band in the reactions with ATG16L1 displays LC3–PE. However, the peptide
ATG16NT(11-43) was not functional.
96
Appendix A.4. Additional lipidation experiments
Figure A.7.: The labeling of ATG16L1 with Atto590 seemed to impair the conjugation
efficiency of the reaction. The quantity of lipidated GUVs (GUVs with bright rims in
merge panel) decreased in samples with labeled ATG16L1. (A) Reaction set up with
LC3A, (B) reaction with LC3B. Scale bar 50 µm.
97
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A.5. Non-starved yeast cells imaged with electron
microscopy
Figure A.8.: Transmission electron microscopy images of whole yeast cells with
pep4 deletion in vegetative conditions, corresponding samples as in Fig. 3.7. (WT)
Wildtype cells, carrying only the pep4 deletion. (ΔAtg18) cells knocked out for Atg18.
Sometimes the vacuole shows accumulation of small lipid droplets (light structures).
(ΔAtg21) Cells with Atg21 knockout (ΔAtg18, ΔAtg21, Atg21 over exprsd)
cells with double knockout of Atg18 and Atg21, overexpressing Atg21. Scale bar 1 µm.
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